[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 284
1. Lehtonen HJ, Kiuru M, Ylisaukko-Oja SK, Salovaara R, Herva R, Koivisto PA, Vierimaa O, Aittomäki K, Pukkala E, Launonen V, Aaltonen LA: Increased risk of cancer in patients with fumarate hydratase germline mutation. J Med Genet; 2006 Jun;43(6):523-6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Hereditary leiomyomatosis and renal cell cancer (HLRCC) is a tumour predisposition syndrome caused by heterozygous germline mutations in the fumarate hydratase (FH) gene.
  • The condition is characterised by predisposition to benign leiomyomas of the skin and the uterus, renal cell carcinoma (RCC), and uterine leiomyosarcoma (ULMS).
  • To comprehensively examine the cancer risk and tumour spectrum in Finnish FH mutation positive families, genealogical and cancer data were obtained from 868 individuals.
  • To study tumour spectrum in FH mutation carriers, loss of the wild type allele was analysed from all available tumours (n = 22).
  • In addition, several benign tumours including atypical uterine leiomyomas, kidney cysts, and adrenal gland adenomas were observed.
  • [MeSH-major] Fumarate Hydratase / genetics. Genetic Predisposition to Disease. Germ-Line Mutation. Neoplasms / genetics
  • [MeSH-minor] Adolescent. Adult. Age Factors. Aged. Carcinoma, Renal Cell / diagnosis. Carcinoma, Renal Cell / genetics. Cohort Studies. Female. Finland. Humans. Kidney Neoplasms / diagnosis. Kidney Neoplasms / genetics. Leiomyomatosis / diagnosis. Leiomyomatosis / genetics. Male. Middle Aged. Phenotype. Risk Factors


2. Temam F, Bizuneh E, Leekassa R: Disseminated form of syringoma (eruptive syringoma) sparing the face-a rare presentation causing diagnostic challenge. Ethiop Med J; 2008 Jul;46(3):273-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Syringomas are benign neoplasms of the skin commonly appearing around the eye lids.
  • The lesions are asymptomatic, firm, discrete, translucent or skin colored flat-topped papules.
  • [MeSH-major] Sweat Gland Neoplasms / pathology. Syringoma / pathology
  • [MeSH-minor] Adult. Diagnosis, Differential. Female. Humans

  • Genetic Alliance. consumer health - Syringoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19271392.001).
  • [ISSN] 0014-1755
  • [Journal-full-title] Ethiopian medical journal
  • [ISO-abbreviation] Ethiop. Med. J.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Ethiopia
  •  go-up   go-down


3. Borenstein M, Mirzabeigi M, Vincek V: Pityrosporum and seborrheic keratosis: an association. Dermatol Online J; 2005;11(2):3
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Seborrheic keratoses (SK) are one of the most common benign tumors of the skin.
  • Studies have suggested that human papillomavirus or a benign clonal proliferation of epidermal cells is involved in the pathogenesis of some SK's, however, this issue remains to be resolved.

  • Genetic Alliance. consumer health - Keratosis, seborrheic.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16150211.001).
  • [ISSN] 1087-2108
  • [Journal-full-title] Dermatology online journal
  • [ISO-abbreviation] Dermatol. Online J.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


Advertisement
4. Rumelt S, Pe'er J, Rubin PA: The clinicopathological spectrum of benign peripunctal tumours. Graefes Arch Clin Exp Ophthalmol; 2005 Feb;243(2):113-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The clinicopathological spectrum of benign peripunctal tumours.
  • The tumours were classified as epithelial and non-epithelial tumours.
  • The tumours included compound and junctional naevi, non-pigmented compound naevus, epithelial, subepithelial inclusion cysts, verrucous and squamous papilloma, pyogenic granuloma and oncocytoma.
  • All the tumours were benign.
  • They involved the peripunctal or canalicular epithelium, the adjacent skin, the glandular epithelium or the subepithelium.
  • Therefore, it is best to ascertain free margins when the tumour is excised.
  • [MeSH-major] Eyelid Neoplasms / pathology
  • [MeSH-minor] Adenoma, Oxyphilic / pathology. Adenoma, Oxyphilic / surgery. Adult. Aged. Diagnosis, Differential. Epidermal Cyst / pathology. Epidermal Cyst / surgery. Female. Granuloma, Pyogenic / pathology. Granuloma, Pyogenic / surgery. Humans. Male. Melanoma, Amelanotic / pathology. Melanoma, Amelanotic / surgery. Middle Aged. Nevus, Pigmented / pathology. Nevus, Pigmented / surgery. Papilloma / pathology. Papilloma / surgery. Retrospective Studies

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Fr Ophtalmol. 2002 Jun;25(6):657-60 [12223957.001]
  • [Cites] Ophthalmology. 1989 Jul;96(7):994-8 [2771365.001]
  • [Cites] Ophthal Plast Reconstr Surg. 1989;5(4):227-34 [2487228.001]
  • [Cites] Ophthalmology. 1997 Mar;104(3):479-84 [9082276.001]
  • [Cites] Am J Ophthalmol. 1993 Sep 15;116(3):385-7 [8357074.001]
  • [Cites] Sb Lek. 1966 Aug;68(8):274-8 [5975497.001]
  • [Cites] Ophthal Plast Reconstr Surg. 1994 Sep;10 (3):169-84 [7947444.001]
  • (PMID = 15558295.001).
  • [ISSN] 0721-832X
  • [Journal-full-title] Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
  • [ISO-abbreviation] Graefes Arch. Clin. Exp. Ophthalmol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


5. Casula M, Alaibac M, Pizzichetta MA, Bono R, Ascierto PA, Stanganelli I, Canzanella S, Palomba G, Zattra E, Italian Melanoma Intergroup (IMI), Palmieri G: Role of the EGF +61A>G polymorphism in melanoma pathogenesis: an experience on a large series of Italian cases and controls. BMC Dermatol; 2009;9:7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: Individuals with less than 10 (N = 127) or more than 100 (N = 128) benign nevi, and patients with cutaneous melanoma (N = 418) were investigated for the EGF +61A>G polymorphism, using an automated sequencing approach.
  • RESULTS: Overall, no difference in EGF genotype frequencies was observed among subjects with different number of nevi as well as when non-melanoma healthy controls were compared with the melanoma patients.
  • [MeSH-major] Epidermal Growth Factor / genetics. Melanoma / genetics. Polymorphism, Single Nucleotide. Skin Neoplasms / genetics

  • MedlinePlus Health Information. consumer health - Melanoma.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Lancet. 2002 Feb 2;359(9304):397-401 [11844511.001]
  • [Cites] Int J Cancer. 2003 Nov 20;107(4):673-5 [14520709.001]
  • [Cites] Cancer Res. 2004 Apr 15;64(8):2668-72 [15087376.001]
  • [Cites] J Invest Dermatol. 2004 Oct;123(4):755-9 [15373781.001]
  • [Cites] Acta Oncol. 2007;46(8):1113-7 [17851837.001]
  • [Cites] Tumour Biol. 1990;11(5):229-61 [2203137.001]
  • [Cites] J Invest Dermatol. 2006 Oct;126(10):2242-6 [16691190.001]
  • [Cites] Eur J Cancer. 2007 Jan;43(1):137-43 [17055252.001]
  • [Cites] J Invest Dermatol. 2004 Oct;123(4):760-2 [15373782.001]
  • (PMID = 19624835.001).
  • [ISSN] 1471-5945
  • [Journal-full-title] BMC dermatology
  • [ISO-abbreviation] BMC Dermatol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 62229-50-9 / Epidermal Growth Factor
  • [Other-IDs] NLM/ PMC2719594
  • [Investigator] Scarrà GB; Sileni VC; Di Filippo F; Maio M; Parmiani G; Queirolo P; Ridolfi R; Rossi C; Testori A
  •  go-up   go-down


6. Ruiz Tovar J, Reguero Callejas ME, Aláez Chillarón AB, Ramiro Pérez C, Collado Guirao MV, Rojo Blanco R, Muñoz Martín-Cámara J, González-Palacios F, García Villanueva A: Mammary hamartoma. Clin Transl Oncol; 2006 Apr;8(4):290-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • INTRODUCTION: Mammary hamartomas are rare benign breast lumps.
  • They are usually painless, wellcircumscribed, mobile and with no adherence to skin or muscle, composed of varying amounts of fat, glandular and fibrous tissue.
  • Because there is no distinct pathological feature, a correlation with the clinical findings and image techniques is necessary in order to achieve a correct diagnosis of the pathology.
  • Other diagnostic procedures used in the diagnosis were Ultrasound, Fine Needle Aspiration Cytology and Needle Core Biopsy.
  • CONCLUSION: Mammary hamartoma is an uncommon breast tumour.
  • [MeSH-minor] Adult. Aged. Biopsy, Fine-Needle. Biopsy, Needle. Breast Neoplasms / complications. Breast Neoplasms / diagnosis. Carcinoma, Ductal, Breast / complications. Carcinoma, Ductal, Breast / diagnosis. Female. Humans. Mammography. Middle Aged. Recurrence. Retrospective Studies. Ultrasonography, Mammary

  • MedlinePlus Health Information. consumer health - Breast Diseases.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Histopathology. 1992 Feb;20(2):99-106 [1559675.001]
  • [Cites] Am J Clin Pathol. 1995 Jun;103(6):685-9 [7785651.001]
  • [Cites] Pathol Res Pract. 1996 Dec;192(12):1187-94 [9182287.001]
  • [Cites] Clin Radiol. 2003 Jan;58(1):80-3 [12565210.001]
  • [Cites] Surg Gynecol Obstet. 1971 Oct;133(4):577-82 [5096305.001]
  • [Cites] J Clin Pathol. 2002 Jul;55(7):541-2 [12101205.001]
  • [Cites] Surg Today. 2001;31(5):433-7 [11381508.001]
  • [Cites] Am J Surg Pathol. 1987 Mar;11(3):234-5 [3826483.001]
  • [Cites] Radiology. 1978 Jan;126(1):95-8 [619444.001]
  • [Cites] Surg Gynecol Obstet. 1991 Jul;173(1):54-6 [1866672.001]
  • [Cites] Am Surg. 1994 Jun;60(6):447-50 [8198338.001]
  • [Cites] J Clin Pathol. 2002 Dec;55(12 ):951-4 [12461066.001]
  • (PMID = 16648106.001).
  • [ISSN] 1699-048X
  • [Journal-full-title] Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
  • [ISO-abbreviation] Clin Transl Oncol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


7. Lin YC, Hsiao PF, Wu YH, Sun FJ, Scher RK: Recurrent digital glomus tumor: analysis of 75 cases. Dermatol Surg; 2010 Sep;36(9):1396-400
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Recurrent digital glomus tumor: analysis of 75 cases.
  • BACKGROUND: Glomus tumors are rare, benign, cutaneous neoplasms that must be excised completely to prevent recurrence.
  • OBJECTIVE: To investigate factors associated with recurrence of glomus tumors after surgery.
  • METHODS AND MATERIALS: Fifty-eight women and 17 men with digital glomus tumors underwent surgery between 1990 and 2008 at our hospital.
  • RESULTS Mean age at diagnosis was 41.8, with an average diagnostic delay of 3.9 years.
  • The tumor was located on a finger in 70 cases (right, 29; left, 41) and a toe in five (right, 3; left, 2).
  • The tumor recurred in 13 (17%) patients.
  • Recurrence was more likely if the tumor was skin-colored (odds ratio (OR)=31.67, 95% confidence interval (CI)=2.68-373.74, p=.006) or located within the nail matrix (OR=5.79, 95% CI=1.03-32.49, p=.046).
  • CONCLUSION: Skin-colored tumors or those in the nail matrix are at higher risk of recurrence.
  • [MeSH-major] Fingers. Glomus Tumor / epidemiology. Glomus Tumor / surgery. Neoplasm Recurrence, Local / epidemiology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © 2010 by the American Society for Dermatologic Surgery, Inc.
  • (PMID = 20629689.001).
  • [ISSN] 1524-4725
  • [Journal-full-title] Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
  • [ISO-abbreviation] Dermatol Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


8. Hafner C, Di Martino E, Pitt E, Stempfl T, Tomlinson D, Hartmann A, Landthaler M, Knowles M, Vogt T: FGFR3 mutation affects cell growth, apoptosis and attachment in keratinocytes. Exp Cell Res; 2010 Jul 15;316(12):2008-16
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • FGFR3 mutations have recently been identified in several benign epidermal skin lesions such as seborrheic keratosis, epidermal nevus and solar lentigo.
  • The functional consequences of these mutations in human skin are as yet unknown.
  • In this study we analyzed the functional effects of the most common FGFR3 mutation in benign skin tumors, the R248C FGFR3 hotspot mutation, in human HaCaT keratinocytes.
  • Our results suggest that an increased cell number at confluence along with a decreased apoptosis may contribute to the development of acanthotic tumors in FGFR3 mutant skin in vivo.

  • Genetics Home Reference. consumer health - epidermal nevus.
  • Genetics Home Reference. consumer health - FGFR3 gene.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20420824.001).
  • [ISSN] 1090-2422
  • [Journal-full-title] Experimental cell research
  • [ISO-abbreviation] Exp. Cell Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] EC 2.7.10.1 / Receptor, Fibroblast Growth Factor, Type 3
  •  go-up   go-down


9. Tran TA, Hayner-Buchan A, Jones DM, McRorie D, Carlson JA: Cutaneous balloon cell dermatofibroma (fibrous histiocytoma). Am J Dermatopathol; 2007 Apr;29(2):197-200
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cutaneous balloon cell dermatofibroma (fibrous histiocytoma).
  • Dermatofibroma (DF) or cutaneous fibrous histiocytoma is a common benign skin tumor that exhibits multiple, distinct histologic variants.
  • Excisional biopsy revealed a circumscribed fibrous tumor populated by mostly clear and spindle cells.
  • A zonal arrangement separated the varied tumor cells where the most superficial, polypoid area showed large, clear polygonal balloon cells; the mid-dermal zone demonstrated a transition between balloon cells, epithelioid cells, and spindle cells; and the deep dermal zone had storiform arrangement of spindle cells, with the fascicles separated by coarse collagen bundles.
  • Ultrastructurally, the clear tumor cells were filled with multiple, empty, nonmembrane bound vacuoles of varying size.
  • DF with balloon cell change, likely secondary to persistent irritation, should be added to the differential diagnosis of cutaneous primary and metastatic neoplasms showing balloon cell degeneration such as balloon cell melanocytic nevi and renal cell carcinoma, respectively.
  • [MeSH-major] Heel. Histiocytoma, Benign Fibrous / pathology. Skin Neoplasms / pathology
  • [MeSH-minor] Adult. Antigens, CD / analysis. Antigens, Differentiation, Myelomonocytic / analysis. Diagnosis, Differential. Factor XIIIa / analysis. Humans. Immunohistochemistry. Male. Microscopy, Electron, Transmission. Neprilysin / analysis. Time Factors. Treatment Outcome. Vacuoles / ultrastructure

  • Genetic Alliance. consumer health - Dermatofibroma.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17414448.001).
  • [ISSN] 0193-1091
  • [Journal-full-title] The American Journal of dermatopathology
  • [ISO-abbreviation] Am J Dermatopathol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, CD; 0 / Antigens, Differentiation, Myelomonocytic; 0 / CD68 antigen, human; EC 2.3.2.13 / Factor XIIIa; EC 3.4.24.11 / Neprilysin
  •  go-up   go-down


10. Rafindadi AH, Samaila MO: Histopathologic analysis of epidermal skin tumours and tumour-like lesions in Ahmadu Bello University Teaching Hospital, Zaria. Niger Postgrad Med J; 2006 Dec;13(4):354-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Histopathologic analysis of epidermal skin tumours and tumour-like lesions in Ahmadu Bello University Teaching Hospital, Zaria.
  • OBJECTIVE: A histopathologic analysis of epidermal skin tumours and tumour-like lesions seen between 1991 - 2000 in the Department of Pathology, Ahmadu Bello University Teaching Hospital [A.B.U.T.H], Zaria is presented.
  • PATIENTS AND METHOD: These tumours were classified according to World Health Organisation's International Histological Classification for Skin Tumours and were tabulated.
  • RESULTS: A total of 350 such lesions comprising 9.9% of all cutaneous neoplasms seen within the study period were collected.
  • Malignant tumours constituted 72.5%; benign tumours 18.3% and tumour-like lesions 9.2%.
  • CONCLUSION: It is concluded that epidermal tumours and tumour-like lesions are not uncommon in Zaria and they show a male preponderance with squamous cell carcinoma being the commonest epidermal tumour and it also predominantly affects males.
  • [MeSH-major] Skin Diseases / epidemiology. Skin Neoplasms / epidemiology. Skin Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • MedlinePlus Health Information. consumer health - Skin Conditions.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17203131.001).
  • [ISSN] 1117-1936
  • [Journal-full-title] The Nigerian postgraduate medical journal
  • [ISO-abbreviation] Niger Postgrad Med J
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Nigeria
  •  go-up   go-down


11. Tu YT, Tao J, Liu YQ, Li Y, Huang CZ, Zhang XB, Lin Y: Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in human malignant melanoma and their relation to angiogenesis. Clin Exp Dermatol; 2006 May;31(3):413-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Angiogenesis is the major and key factor for growth and invasion of tumours, including malignant melanoma (MM), but the factors that contribute to tumour angiogenesis are still unclear.
  • CONCLUSIONS. On the basis of the current data showing that malignant melanocytic tumours displayed strong VEGF and eNOS expression, whereas benign melanocytic proliferations showed no immunoreactivity for VEGF and eNOS, such expression may be used as a discriminating factor to distinguish malignant melanoma from pigmented naevi.
  • [MeSH-major] Biomarkers, Tumor / analysis. Melanoma / chemistry. Nitric Oxide Synthase Type III / analysis. Skin Neoplasms / chemistry. Vascular Endothelial Growth Factor A / analysis

  • MedlinePlus Health Information. consumer health - Melanoma.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • Hazardous Substances Data Bank. NITRIC OXIDE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16681591.001).
  • [ISSN] 0307-6938
  • [Journal-full-title] Clinical and experimental dermatology
  • [ISO-abbreviation] Clin. Exp. Dermatol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Vascular Endothelial Growth Factor A; 31C4KY9ESH / Nitric Oxide; EC 1.14.13.39 / Nitric Oxide Synthase Type III
  •  go-up   go-down


12. Fleming DM, Cross KW, Barley MA: Recent changes in the prevalence of diseases presenting for health care. Br J Gen Pract; 2005 Aug;55(517):589-95
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Age-standardised prevalence rates per 10,000 registered persons and 99% confidence intervals (CIs) were calculated using the national census population for 2001 as the standard.
  • Survey differences in prevalence were identified from non-overlapping CIs.
  • The prevalence of mental disorders, skin disease and musculoskeletal disorders showed little change.
  • Particular increases were noted for other malignant and benign neoplasms of the skin, hypothyroidism and diabetes.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] BMJ. 2003 Jun 28;326(7404):1439-43 [12829558.001]
  • [Cites] BMJ. 2002 Dec 14;325(7377):1397-8 [12480857.001]
  • [Cites] Arch Dis Child. 2004 Mar;89(3):282-5 [14977715.001]
  • [Cites] Eur J Public Health. 2004 Mar;14(1):10-4 [15080383.001]
  • [Cites] J Epidemiol Community Health. 1991 Sep;45(3):180-3 [1757757.001]
  • [Cites] BMJ. 1998 May 23;316(7144):1572-6 [9596597.001]
  • [Cites] Commun Dis Rep CDR Suppl. 1998 Dec;8(7):S1-11 [9879128.001]
  • [Cites] Commun Dis Public Health. 1999 Jun;2(2):96-100 [10402742.001]
  • [Cites] Diabetologia. 1999 Jul;42(7):793-801 [10440120.001]
  • [Cites] Eur J Epidemiol. 1999 May;15(5):467-73 [10442473.001]
  • [Cites] Br J Gen Pract. 2003 Oct;53(495):778-83 [14601353.001]
  • [Cites] Thorax. 2000 Aug;55(8):662-5 [10899242.001]
  • [Cites] Commun Dis Public Health. 2000 Sep;3(3):213-5 [11014039.001]
  • [Cites] Diabet Med. 2001 Feb;18(2):126-32 [11251676.001]
  • [Cites] N Engl J Med. 2001 May 3;344(18):1343-50 [11333990.001]
  • [Cites] Br J Gen Pract. 2001 Aug;51(469):638-43 [11510393.001]
  • [CommentIn] Br J Gen Pract. 2005 Nov;55(520):884 [16282011.001]
  • (PMID = 16105366.001).
  • [ISSN] 0960-1643
  • [Journal-full-title] The British journal of general practice : the journal of the Royal College of General Practitioners
  • [ISO-abbreviation] Br J Gen Pract
  • [Language] eng
  • [Publication-type] Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC1463227
  •  go-up   go-down


13. Schöniger S, Tivers MS, Baines SJ, Summers BA: Arteriovenous haemangioma in two dogs and a cat. J Comp Pathol; 2008 Aug-Oct;139(2-3):130-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Haemangiomas are benign vascular tumours and several types can be distinguished based on microscopical features.
  • One dog and the cat presented with a cutaneous vascular lesion, the other dog with a bleeding mass in the tongue.
  • Surgically excised masses comprised non-encapsulated proliferations of variably sized arterial- and venous-like vessels, accompanied by clusters of capillaries and immature vascular structures in the feline cutaneous tumour and the canine lingual neoplasm.
  • The results of this study expand the range of differential diagnoses for vascular neoplasms in the dog and cat.
  • [MeSH-major] Cat Diseases / pathology. Dog Diseases / pathology. Hemangioma / veterinary. Skin Neoplasms / veterinary. Tongue Neoplasms / veterinary

  • MedlinePlus Health Information. consumer health - Birthmarks.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18620702.001).
  • [ISSN] 0021-9975
  • [Journal-full-title] Journal of comparative pathology
  • [ISO-abbreviation] J. Comp. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down


14. Michailidou C, Jones M, Walker P, Kamarashev J, Kelly A, Hurlstone AF: Dissecting the roles of Raf- and PI3K-signalling pathways in melanoma formation and progression in a zebrafish model. Dis Model Mech; 2009 Jul-Aug;2(7-8):399-411
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Deregulated Ras signalling is implicated in most human neoplasia, exemplified by melanoma.
  • Whereas Raf activation occurs almost ubiquitously in benign and malignant melanocytic neoplasms, implying an involvement in tumour initiation, phosphoinositide 3-kinase (PI3K) activation occurs predominantly in malignant neoplasms, implying an involvement in malignant progression.
  • Misexpression of effector-domain mutants of V12RAS, or of various downstream effectors, confirmed a selective role for the Raf-Mek-Erk pathway in initiating neoplasia, but highlighted the requirement for additional Ras effector pathways for malignancy.
  • [MeSH-minor] Animals. Cell Differentiation. Cell Line. Disease Models, Animal. Disease Progression. Humans. Mice. Mutation. Neoplasm Invasiveness. Protein Isoforms. Signal Transduction. Skin Neoplasms / metabolism. Zebrafish

  • MedlinePlus Health Information. consumer health - Melanoma.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • ZFIN. ZFIN .
  • Zurich Open Access Repository and Archive. Full text from .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19470611.001).
  • [ISSN] 1754-8411
  • [Journal-full-title] Disease models & mechanisms
  • [ISO-abbreviation] Dis Model Mech
  • [Language] eng
  • [Grant] United Kingdom / Cancer Research UK / / ; United Kingdom / Wellcome Trust / /
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Protein Isoforms; EC 2.7.1.- / Phosphatidylinositol 3-Kinases; EC 2.7.11.1 / raf Kinases
  •  go-up   go-down


15. Ikeda F, Dikic I: CYLD in ubiquitin signaling and tumor pathogenesis. Cell; 2006 May 19;125(4):643-5
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] CYLD in ubiquitin signaling and tumor pathogenesis.
  • Absence of CYLD, which encodes a deubiquitinating enzyme, causes an inherited disease characterized by benign skin tumors.
  • [MeSH-major] Neoplasms / metabolism. Signal Transduction / physiology. Tumor Suppressor Proteins / metabolism. Ubiquitin / metabolism
  • [MeSH-minor] Genes, Tumor Suppressor. Humans. NF-kappa B / metabolism. Proto-Oncogene Proteins / metabolism. Transcription Factors

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentOn] Cell. 2006 May 19;125(4):665-77 [16713561.001]
  • (PMID = 16713556.001).
  • [ISSN] 0092-8674
  • [Journal-full-title] Cell
  • [ISO-abbreviation] Cell
  • [Language] eng
  • [Publication-type] Comment; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / CYLD protein, human; 0 / NF-kappa B; 0 / Proto-Oncogene Proteins; 0 / Transcription Factors; 0 / Tumor Suppressor Proteins; 0 / Ubiquitin; 0 / proto-oncogene protein bcl-3
  •  go-up   go-down


16. Savoia P, Fava P, Osella-Abate S, Nardò T, Comessatti A, Quaglino P, Bernengo MG: Melanoma of unknown primary site: a 33-year experience at the Turin Melanoma Centre. Melanoma Res; 2010 Jun;20(3):227-32
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Melanoma of unknown primary site: a 33-year experience at the Turin Melanoma Centre.
  • Unknown melanoma occurs as metastasis to skin, nodes or viscera, without a detectable cutaneous primary tumour.
  • We identified 93 cases of metastatic melanoma without evidence of primary; however, five of these patients had a history of a previous excision of a presumed benign lesion without histological examination and were excluded from analyses.
  • At diagnosis, metastases were cutaneous in 35.3% of cases, nodal in 43.2% and visceral in 17% of cases; in 4.5% of patients, both skin and nodes were involved.
  • In all cases, clinical inspection and staging procedures performed at diagnosis of metastatic disease failed to identify a primary melanoma.
  • Survival was longer in females and showed significant differences among patients with skin, lymph node or visceral involvement at diagnosis.
  • [MeSH-major] Melanoma / diagnosis. Melanoma / therapy. Skin Neoplasms / diagnosis. Skin Neoplasms / therapy

  • MedlinePlus Health Information. consumer health - Melanoma.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • COS Scholar Universe. author profiles.
  • University of Turin Instituional Repository AperTO. Full Text from .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20449885.001).
  • [ISSN] 1473-5636
  • [Journal-full-title] Melanoma research
  • [ISO-abbreviation] Melanoma Res.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] EC 1.14.18.1 / Monophenol Monooxygenase
  •  go-up   go-down


17. El Ibrahimi A, Daoudi A, Znati K, Elmrini A, Boutayeb F: [Insulated leg pilomatrixoma: a rare localization]. Ann Chir Plast Esthet; 2009 Aug;54(4):388-91
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Transliterated title] Pilomatricome isolé de la jambe. Une rare localisation.
  • Pilomatrixoma is a benign skin neoplasm of the hair follicle.
  • It's usually misdiagnosed and confused with other skin lesions.
  • [MeSH-major] Hair Diseases. Leg. Pilomatrixoma. Skin Neoplasms

  • Genetic Alliance. consumer health - Pilomatrixoma.
  • MedlinePlus Health Information. consumer health - Hair Problems.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19195758.001).
  • [ISSN] 1768-319X
  • [Journal-full-title] Annales de chirurgie plastique et esthétique
  • [ISO-abbreviation] Ann Chir Plast Esthet
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


18. De Felice B, Garbi C, Santoriello M, Santillo A, Wilson RR: Differential apoptosis markers in human keloids and hypertrophic scars fibroblasts. Mol Cell Biochem; 2009 Jul;327(1-2):191-201
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Keloids are benign skin tumors and are the effect of a dysregulated wound-healing process in genetically predisposed patients.
  • [MeSH-minor] Adult. Biomarkers / metabolism. Cells, Cultured. Female. Humans. Male. Reactive Oxygen Species / metabolism. Tumor Suppressor Protein p53 / genetics. Tumor Suppressor Protein p53 / metabolism. Wound Healing

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] DNA Cell Biol. 2007 Aug;26(8):541-7 [17688405.001]
  • [Cites] Ann Plast Surg. 2005 Jul;55(1):69-75; discussion 75 [15985794.001]
  • [Cites] J Am Acad Dermatol. 1995 Jul;33(1):117-23 [7601928.001]
  • [Cites] Proc Natl Acad Sci U S A. 1980 Aug;77(8):4420-4 [6254023.001]
  • [Cites] Wound Repair Regen. 1998 Jan-Feb;6(1):28-37 [9776848.001]
  • [Cites] Arch Dermatol. 1998 Aug;134(8):963-7 [9722726.001]
  • [Cites] Science. 1994 Jul 15;265(5170):346-55 [8023157.001]
  • [Cites] Trends Pharmacol Sci. 2004 Apr;25(4):177-81 [15116721.001]
  • [Cites] Nat Rev Mol Cell Biol. 2000 Dec;1(3):199-207 [11252895.001]
  • [Cites] Zhonghua Zheng Xing Wai Ke Za Zhi. 2003 Mar;19(2):95-7 [12889183.001]
  • [Cites] Cancer Res. 2000 Jul 1;60(13):3370-4 [10910040.001]
  • [Cites] Neurosci Lett. 2003 Dec 4;352(2):105-8 [14625034.001]
  • [Cites] J Cell Sci. 2006 Dec 15;119(Pt 24):5015-20 [17158908.001]
  • [Cites] Blood. 1997 Jun 1;89(11):4175-81 [9166861.001]
  • [Cites] Am J Pathol. 1994 Jul;145(1):105-13 [8030742.001]
  • [Cites] Int J Oncol. 1999 Dec;15(6):1149-53 [10568821.001]
  • [Cites] Blood. 1997 Mar 1;89(5):1748-53 [9057659.001]
  • [Cites] J Dermatol Sci. 2004 Feb;34(1):17-24 [14757278.001]
  • [Cites] Hum Genet. 1993 Mar;91(1):25-30 [8454284.001]
  • [Cites] Wound Repair Regen. 2007 Sep-Oct;15 Suppl 1:S6-17 [17727469.001]
  • [Cites] Differentiation. 1991 Apr;46(3):181-6 [1655543.001]
  • [Cites] Science. 1991 Jul 5;253(5015):49-53 [1905840.001]
  • [Cites] Nat Rev Cancer. 2002 Aug;2(8):594-604 [12154352.001]
  • [Cites] J Cell Biochem. 2007 Mar 1;100(4):883-96 [17031865.001]
  • [Cites] Am J Pathol. 1995 Sep;147(3):790-8 [7677190.001]
  • [Cites] J Cell Physiol. 2004 Mar;198(3):350-8 [14755540.001]
  • [Cites] Chem Res Toxicol. 1997 Apr;10(4):393-400 [9114975.001]
  • [Cites] Zhonghua Shao Shang Za Zhi. 2004 Apr;20(2):85-7 [15312469.001]
  • [Cites] Curr Opin Pediatr. 2006 Aug;18(4):396-402 [16914994.001]
  • [Cites] J Surg Res. 1993 Aug;55(2):214-22 [8412102.001]
  • [Cites] Mol Genet Genomics. 2004 Aug;272(1):28-34 [15248062.001]
  • [Cites] Trends Mol Med. 2006 Sep;12(9):440-50 [16899408.001]
  • [Cites] Apoptosis. 2000 Nov;5(5):415-8 [11256882.001]
  • [Cites] Dermatol Surg. 2008 Mar;34(3):336-46 [18177398.001]
  • [Cites] Oncogene. 1998 Nov 26;17(21):2753-60 [9840939.001]
  • [Cites] Neuron. 1995 Feb;14(2):303-15 [7857640.001]
  • [Cites] Plast Reconstr Surg. 2007 May;119(6):1714-21 [17440345.001]
  • [Cites] Proc Natl Acad Sci U S A. 1992 Aug 1;89(15):7262-6 [1353891.001]
  • [Cites] Proc Natl Acad Sci U S A. 1991 Oct 1;88(19):8405-9 [1924299.001]
  • [Cites] Ann Plast Surg. 2005 Jun;54(6):676-80 [15900161.001]
  • [Cites] Plast Reconstr Surg. 2001 Mar;107(3):797-808 [11304607.001]
  • [Cites] Int J Cancer. 2000 Jun 1;86(5):684-9 [10797291.001]
  • [Cites] Proc Natl Acad Sci U S A. 1989 Jan;86(1):232-6 [2643100.001]
  • [Cites] Oncogene. 1999 Nov 1;18(45):6145-57 [10557106.001]
  • [Cites] J Pathol. 1999 Jan;187(1):112-26 [10341712.001]
  • [Cites] Wound Repair Regen. 1999 Nov-Dec;7(6):511-7 [10633011.001]
  • [Cites] Nature. 2000 Nov 16;408(6810):307-10 [11099028.001]
  • [Cites] Cell Mol Life Sci. 1999 Jan;55(1):28-37 [10065149.001]
  • [Cites] Zhonghua Zheng Xing Wai Ke Za Zhi. 2003 Jul;19(4):258-60 [14628411.001]
  • (PMID = 19224335.001).
  • [ISSN] 1573-4919
  • [Journal-full-title] Molecular and cellular biochemistry
  • [ISO-abbreviation] Mol. Cell. Biochem.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Biomarkers; 0 / Reactive Oxygen Species; 0 / Tumor Suppressor Protein p53
  •  go-up   go-down


19. Sparsa A, Bonnetblanc JM, Roux C, Pinet C, Loustaud-Ratti V, Boulinguez S, Labrousse F, Vidal E, Bedane C: [Pyogenic granuloma revealing fistula and deep infection: five cases]. Ann Dermatol Venereol; 2006 Oct;133(10):763-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Pyogenic granuloma, or botryomycosis, occurring after minor injury or scratching with a septic implement, is a rapidly growing benign inflammatory vascular tumour, often involving the skin or mucous membrane.
  • Clinical images were recorded and a diagnosis of botryomycosis was confirmed in all patients by histological analysis.
  • The time from initial clinical signs to diagnosis, presence of traumatic events, screening for microscopic organisms, response to systemic antibiotic therapy, recurrence and clinical features of botriomycosis were analysed.
  • [MeSH-major] Cutaneous Fistula / etiology. Granuloma, Pyogenic / complications. Skin Diseases / complications

  • Genetic Alliance. consumer health - Pyogenic Granuloma.
  • MedlinePlus Health Information. consumer health - Skin Conditions.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17072190.001).
  • [ISSN] 0151-9638
  • [Journal-full-title] Annales de dermatologie et de vénéréologie
  • [ISO-abbreviation] Ann Dermatol Venereol
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


20. Singh SS, Velusami SD: Syringomatous adenoma of the nipple: report of a case. Indian J Pathol Microbiol; 2007 Oct;50(4):808-11
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Syringomatous adenoma of the nipple is a rarely encountered neoplasm of the breast with histological features similar to eccrine syringoma of the skin.
  • This tumour which is locally invasive with high potential for recurrence if incompletely excised is considered benign and a complete excision is sufficient.
  • A clinicopathological study and histological differential diagnosis of this unusual tumour is described.
  • [MeSH-major] Nipples / pathology. Syringoma / diagnosis. Syringoma / pathology
  • [MeSH-minor] Biopsy. Diagnosis, Differential. Female. Humans. Mammography. Middle Aged

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18306564.001).
  • [ISSN] 0377-4929
  • [Journal-full-title] Indian journal of pathology & microbiology
  • [ISO-abbreviation] Indian J Pathol Microbiol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] India
  •  go-up   go-down


21. Bezdekova M, Brychtova S, Sedlakova E, Steigerova J, Hlobilkova A, Bienova M, Kucerova R, Brychta T, Krejci V, Kolar Z: Immunohistochemical assessment of E-cadherin and beta-catenin in trichofolliculomas and trichoepitheliomas. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2007 Dec;151(2):251-5
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Trichofolliculomas and trichoepitheliomas are benign skin neoplasms originating from hair follicle cells.
  • It is known that the E-cadherin/beta-catenin system of adhesion molecules plays a crucial role in the maintenance of tissue architecture.
  • AIM: The aim of the present study was to investigate their involvement in benign hair follicle tumor development.
  • METHODS: Semiquantitative intensity of expression were examined in formalin-fixed and paraffin-embedded tissue sections of 53 trichoepitheliomas, 15 trichofolliculomas and 19 normal skin samples by indirect immunohistochemistry.
  • RESULTS: The intensity of E-cadherin/beta-catenin expression in tumor cells did not differ from controls.
  • However, normal hair follicles cells exhibited membranous E-cadherin/beta-catenin expression, whereas both types of tumors, particularly trichoepitheliomas, showed E-cadherin/beta-catenin expression with a predominantly cytoplasmic localization.
  • CONCLUSIONS: We suggest that this dystopic distribution of the E-cadherin/beta-catenin complex in hair follicle tumor cells may be a marker of cell-cell adhesion disruption which may contribute to the tumor formation.
  • [MeSH-major] Cadherins / analysis. Hair Diseases / metabolism. Neoplasms, Basal Cell / chemistry. Skin Neoplasms / chemistry. beta Catenin / analysis

  • MedlinePlus Health Information. consumer health - Hair Problems.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18345259.001).
  • [ISSN] 1213-8118
  • [Journal-full-title] Biomedical papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia
  • [ISO-abbreviation] Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Czech Republic
  • [Chemical-registry-number] 0 / Cadherins; 0 / beta Catenin
  •  go-up   go-down


22. Kohlhof JK, Müller-Richter U, Driemel O, Sachs H: [Pleomorphic malignant fibrous histiocytoma of the periorbital region]. Klin Monbl Augenheilkd; 2007 Mar;224(3):203-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Transliterated title] Pleomorphes malignes fibröses Histiozytom der Periorbitalregion.
  • PATIENT: A 91 year old female patient presented because of a prominent tumour in the upper right periorbital region.
  • As stated in the case history, the tumour had developed within the previous 6 months.
  • The tumour measured about 3 x 4 cm.
  • Due to the mass of the tumour a ptosis was present.
  • CLINIC: Neither CT nor MRI could give a clue to the tumour entity.
  • A biopsy was classified as a malignant fibrous tumour with the subclassification of an atypical fibroxanthoma.
  • The final histopathological classification after total excision of the tumour showed perineural growth and angioinvasion.
  • Therefore the tumour classification was changed to pleomorphic malignant fibrous histiocytoma (undifferentiated pleomorphic sarcoma).
  • The defect was closed with a full skin graft on the basis of a galea periosteal flap.
  • CONCLUSION: The histopathological examination could not provide the correct diagnosis initially.
  • Immunohistochemical stainings (Vimentin) were carried out to characterise the tumour.
  • This underlines that even with state of the art procedures the classification of neoplasias can be very difficult.
  • In the process of finding the right diagnosis sometimes a change from benign to malignant occurs and alters the treatment regime.
  • [MeSH-major] Histiocytoma, Malignant Fibrous / pathology. Histiocytoma, Malignant Fibrous / radiography. Orbital Neoplasms / pathology. Orbital Neoplasms / radiography


23. Clarke LE, Zhang PJ, Crawford GH, Elenitsas R: Myxofibrosarcoma in the skin. J Cutan Pathol; 2008 Oct;35(10):935-40
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Myxofibrosarcoma in the skin.
  • Myxofibrosarcoma, also known as myxoid malignant fibrous histiocytoma, is increasingly recognized as a distinct malignant neoplasm of fibroblastic origin with variable clinical and histopathologic features.
  • Myxofibrosarcomas are among the most common malignant mesenchymal neoplasms of older adults, and approximately two thirds develop within the dermis or subcutis.
  • Herein, we describe the clinicopathologic features of four cases of myxofibrosarcoma involving the skin.
  • Three of these cases were initially misdiagnosed as benign cutaneous neoplasms, two as myxoid neurofibroma.
  • These cases illustrate the clinicopathologic spectrum encompassed by myxofibrosarcoma in the skin and highlight the diagnostic difficulties it may present.
  • [MeSH-major] Fibrosarcoma / pathology. Skin Neoplasms / pathology
  • [MeSH-minor] Aged. Diagnosis, Differential. Female. Fibroma / pathology. Humans. Immunohistochemistry. Male. Middle Aged. Neurofibroma / pathology

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18494817.001).
  • [ISSN] 1600-0560
  • [Journal-full-title] Journal of cutaneous pathology
  • [ISO-abbreviation] J. Cutan. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Denmark
  •  go-up   go-down


24. Pestoni C, Paredes-Suarez C, Peteiro C, Toribio J: Early detection of cutaneous angiosarcoma of the face and scalp and treatment with placitaxel. J Eur Acad Dermatol Venereol; 2005 May;19(3):357-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Early detection of cutaneous angiosarcoma of the face and scalp and treatment with placitaxel.
  • Cutaneous angiosarcoma (AS) of the face and scalp of the elderly is a rare malignant tumour with a very poor prognosis.
  • The variable presentation and the benign appearance of the cutaneous AS may often delay the correct diagnosis.
  • We describe a case of an old man who was diagnosed of AS of the face and scalp 1 month after developing the cutaneous lesion.
  • Unfortunately, he developed pulmonary fibrosis and died 6 months after diagnosis.
  • [MeSH-major] Antineoplastic Agents, Phytogenic / therapeutic use. Facial Neoplasms / diagnosis. Head and Neck Neoplasms / diagnosis. Hemangiosarcoma / diagnosis. Paclitaxel / therapeutic use. Scalp. Skin Neoplasms / diagnosis

  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • Hazardous Substances Data Bank. TAXOL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15857466.001).
  • [ISSN] 0926-9959
  • [Journal-full-title] Journal of the European Academy of Dermatology and Venereology : JEADV
  • [ISO-abbreviation] J Eur Acad Dermatol Venereol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Antineoplastic Agents, Phytogenic; P88XT4IS4D / Paclitaxel
  •  go-up   go-down


25. Niang SO, Kane A, Diallo M, Choutah F, Dieng MT, Ndiaye B: Dermatosis papulosa nigra in Dakar, Senegal. Int J Dermatol; 2007 Oct;46 Suppl 1:45-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Dermatosis papulosa nigra (DPN) is a benign epithelial tumour, common in the black population.
  • Its benign character has meant that very few studies have been performed.
  • The diagnosis of DPN was clinical.
  • [MeSH-major] Keratosis, Seborrheic / epidemiology. Skin Neoplasms / epidemiology

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17919208.001).
  • [ISSN] 0011-9059
  • [Journal-full-title] International journal of dermatology
  • [ISO-abbreviation] Int. J. Dermatol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


26. Mukaratirwa S, Chipunza J, Chitanga S, Chimonyo M, Bhebhe E: Canine cutaneous neoplasms: prevalence and influence of age, sex and site on the presence and potential malignancy of cutaneous neoplasms in dogs from Zimbabwe. J S Afr Vet Assoc; 2005 Jun;76(2):59-62
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Canine cutaneous neoplasms: prevalence and influence of age, sex and site on the presence and potential malignancy of cutaneous neoplasms in dogs from Zimbabwe.
  • Histopathological examination was performed on cutaneous biopsies from 900 dogs with skin lesions from Zimbabwe, collected from 1996 to 2000.
  • Sixty per cent (540/900) of the cases were tumours and 40% (360/900) were non-neoplastic inflammatory or degenerative diseases.
  • Thirty different histological types of tumour were diagnosed.
  • The 10 most common tumours, comprising 73.7% of all cutaneous neoplasms, were mast cell tumours, squamous cell carcinomas, perianal gland adenomas, lymphomas, benign melanomas, haemangiosarcomas, sebaceous gland adenomas, fibrosarcomas, lipomas and malignant melanomas.
  • The prevalence of various neoplasms, age of affected dogs and sites of occurrence were similar to surveys in other countries, except that in Zimbabwe there was a greater prevalence of lymphomas and of tumours associated with increased exposure to ultraviolet light (squamous cell carcinomas, haemangiosarcomas and melanomas).
  • For all classes of tumours the sex of the dog did not have any significant influence on the likelihood of developing a tumour.
  • For a dog diagnosed with a tumour located on the trunk, the tumour was significantly more likely to be an epithelial tumour than a non-epithelial tumour The occurrence of melanocytic tumours on the trunk was significantly lower than at other sites.
  • [MeSH-major] Dog Diseases / epidemiology. Dog Diseases / pathology. Skin Neoplasms / veterinary

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16108522.001).
  • [ISSN] 1019-9128
  • [Journal-full-title] Journal of the South African Veterinary Association
  • [ISO-abbreviation] J S Afr Vet Assoc
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] South Africa
  •  go-up   go-down


27. Mukaratirwa S, Chikafa L, Dliwayo R, Moyo N: Mast cells and angiogenesis in canine melanomas: malignancy and clinicopathological factors. Vet Dermatol; 2006 Apr;17(2):141-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Eighty canine melanomas (56 malignant and 24 benign), investigated to determine the relationship between mast cell count (MCC), microvessel density (MVD) and clinicopathology, revealed significantly higher MCC and MVD counts in malignant melanomas.
  • Evaluation of the prognostic significance of MCC and MVD in malignant melanomas showed a significant correlation between MCC and MVD both within and at the edges of the tumour.
  • [MeSH-major] Dog Diseases / pathology. Melanoma / veterinary. Skin Neoplasms / veterinary

  • MedlinePlus Health Information. consumer health - Melanoma.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Vet Dermatol. 2006 Aug;17(4):284-6; discussion 289 [16827673.001]
  • [CommentIn] Vet Dermatol. 2006 Aug;17(4):287-8; discussion 289 [16827674.001]
  • (PMID = 16515657.001).
  • [ISSN] 0959-4493
  • [Journal-full-title] Veterinary dermatology
  • [ISO-abbreviation] Vet. Dermatol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


28. Betz CS, Jäger HR, Brookes JA, Richards R, Leunig A, Hopper C: Interstitial photodynamic therapy for a symptom-targeted treatment of complex vascular malformations in the head and neck region. Lasers Surg Med; 2007 Aug;39(7):571-82
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The light can be applied by surface illumination or directly into tumour tissue by optical fibres.
  • This raises the possibility of using this therapy in the treatment of benign neoplasms in the head and neck.
  • RESULTS: In all cases there was a significant reduction in the volume of abnormal tissue without damage to the overlying skin; the results were objectified using MRI-imaging, CT-volumetry and surface optical scanning.
  • Post-treatment pain and swelling were successfully controlled with steroids and a variety of analgesics (opioids and non-steroidal anti-inflammatories).
  • CONCLUSION: This minimally invasive approach to treat complex benign neoplasias seems promising.
  • [MeSH-minor] Adult. Diagnosis, Differential. Follow-Up Studies. Head. Humans. Magnetic Resonance Imaging. Male. Middle Aged. Neck. Retrospective Studies. Tomography, X-Ray Computed

  • Genetic Alliance. consumer health - Vascular Malformations.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17868106.001).
  • [ISSN] 0196-8092
  • [Journal-full-title] Lasers in surgery and medicine
  • [ISO-abbreviation] Lasers Surg Med
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Mesoporphyrins; 0 / Photosensitizing Agents; FU21S769PF / temoporfin
  •  go-up   go-down


29. Ferguson B, Konrad Muller H, Handoko HY, Khosrotehrani K, Beermann F, Hacker E, Soyer HP, Bosenberg M, Walker GJ: Differential roles of the pRb and Arf/p53 pathways in murine naevus and melanoma genesis. Pigment Cell Melanoma Res; 2010 Dec;23(6):771-80
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We report on a systematic analysis of genotype-specific melanocyte (MC) UVR responses in transgenic mouse melanoma models along with tumour penetrance and comparative histopathology. pRb or p53 pathway mutations cooperated with Nras(Q61K) to transform MCs.
  • In animals carrying the Arf or p53 defects, no naevi were detected, with all tumours ostensibly skipping the benign precursor stage in progression.
  • [MeSH-major] Melanoma / metabolism. Nevus / metabolism. Precancerous Conditions / pathology. Retinoblastoma Protein / metabolism. Signal Transduction. Tumor Suppressor Protein p14ARF / metabolism. Tumor Suppressor Protein p53 / metabolism
  • [MeSH-minor] Animals. Animals, Newborn. Cell Count. Cell Movement / radiation effects. Cell Proliferation / radiation effects. Cyclin-Dependent Kinase 4 / metabolism. Melanocytes / pathology. Melanocytes / radiation effects. Mice. Models, Biological. Penetrance. Skin Neoplasms / genetics. Skin Neoplasms / metabolism. Skin Neoplasms / pathology. Ultraviolet Rays

  • MedlinePlus Health Information. consumer health - Birthmarks.
  • MedlinePlus Health Information. consumer health - Melanoma.
  • MedlinePlus Health Information. consumer health - Moles.
  • Mouse Genome Informatics (MGI). Mouse Genome Informatics (MGI) .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20718941.001).
  • [ISSN] 1755-148X
  • [Journal-full-title] Pigment cell & melanoma research
  • [ISO-abbreviation] Pigment Cell Melanoma Res
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Retinoblastoma Protein; 0 / Tumor Suppressor Protein p14ARF; 0 / Tumor Suppressor Protein p53; EC 2.7.11.22 / Cdk4 protein, mouse; EC 2.7.11.22 / Cyclin-Dependent Kinase 4
  •  go-up   go-down


30. Chechlinska M, Kowalewska M, Brzoska-Wojtowicz E, Radziszewski J, Ptaszynski K, Rys J, Kaminska J, Nowak R: Squamous cell carcinoma antigen 1 and 2 expression in cultured normal peripheral blood mononuclear cells and in vulvar squamous cell carcinoma. Tumour Biol; 2010 Dec;31(6):559-67
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Serum levels of SCCA are elevated in patients with benign skin diseases and in patients with SCC.
  • In VSCC, in addition to tumour itself, metastatic lymph nodes seem also to be a potential source of serum SCCA.
  • [MeSH-major] Antigens, Neoplasm / metabolism. Carcinoma, Squamous Cell / metabolism. Leukocytes, Mononuclear / metabolism. Serpins / metabolism. Vulvar Neoplasms / metabolism
  • [MeSH-minor] Biomarkers, Tumor / metabolism. Cell Line, Tumor. Cells, Cultured. Female. Humans. RNA, Messenger / metabolism

  • Genetic Alliance. consumer health - Carcinoma, Squamous Cell.
  • MedlinePlus Health Information. consumer health - Vulvar Cancer.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Eur J Cancer. 2006 Nov;42(16):2671-4 [16978860.001]
  • [Cites] Tumour Biol. 2006;27(3):142-52 [16641548.001]
  • [Cites] FEBS Lett. 2007 Sep 4;581(22):4260-4 [17707374.001]
  • [Cites] Crit Rev Oncol Hematol. 2008 Apr;66(1):10-20 [17964182.001]
  • [Cites] Nat Rev Cancer. 2010 Jan;10(1):2-3 [20050335.001]
  • [Cites] J Gene Med. 2010 Jun;12(6):545-54 [20527047.001]
  • [Cites] J Histochem Cytochem. 2000 Jan;48(1):113-22 [10653592.001]
  • [Cites] Int J Cancer. 2000 Jul 20;89(4):368-77 [10956412.001]
  • [Cites] Oncol Rep. 2001 Mar-Apr;8(2):347-54 [11182054.001]
  • [Cites] Int J Cancer. 2001 Jan 20;95(1):39-43 [11241309.001]
  • [Cites] Cancer Lett. 2001 Jun 26;167(2):205-13 [11369142.001]
  • [Cites] Eur J Cancer. 2002 Oct;38(15):1987-91 [12376202.001]
  • [Cites] J Reprod Med. 2002 Sep;47(9):718-20 [12380452.001]
  • [Cites] Cytokine. 2002 Sep 21;19(6):287-96 [12421571.001]
  • [Cites] Neoplasma. 2004;51(2):103-9 [15190419.001]
  • [Cites] Cancer. 1977 Oct;40(4):1621-8 [332328.001]
  • [Cites] J Cell Biol. 1988 Mar;106(3):761-71 [2450098.001]
  • [Cites] Cancer. 1989 Oct 15;64(8):1652-6 [2790678.001]
  • [Cites] Gynecol Oncol. 1989 Nov;35(2):227-32 [2807015.001]
  • [Cites] Clin Chem. 1990 Feb;36(2):251-4 [2302769.001]
  • [Cites] Biochem Biophys Res Commun. 1991 Nov 27;181(1):51-8 [1958219.001]
  • [Cites] Cancer. 1990 Oct 1;66(7):1505-12 [2208001.001]
  • [Cites] J Am Acad Dermatol. 1990 Apr;22(4):639-42 [2319025.001]
  • [Cites] Chest. 1994 Mar;105(3):773-6 [8131539.001]
  • [Cites] J Dermatol. 1994 Feb;21(2):67-72 [8182213.001]
  • [Cites] Cancer. 1995 Sep 1;76(5):758-64 [8625177.001]
  • [Cites] Tumour Biol. 1996;17(2):81-9 [8658017.001]
  • [Cites] J Biol Chem. 1997 Jan 17;272(3):1849-55 [8999871.001]
  • [Cites] Int J Cancer. 1997 Feb 20;74(1):75-80 [9036873.001]
  • [Cites] Biochemistry. 1998 Apr 14;37(15):5258-66 [9548757.001]
  • [Cites] Tumour Biol. 1998;19(6):517-26 [9817981.001]
  • [Cites] Int J Cancer. 1999 Oct 8;83(2):167-70 [10471522.001]
  • [Cites] J Biol Chem. 2005 Mar 18;280(11):9761-4 [15677460.001]
  • [Cites] Gynecol Oncol. 2005 Jun;97(3):904-7 [15894354.001]
  • [Cites] Clin Exp Allergy. 2005 Oct;35(10):1327-33 [16238792.001]
  • [Cites] Int J Gynecol Cancer. 2007 Jan-Feb;17(1):174-81 [17291250.001]
  • (PMID = 20589490.001).
  • [ISSN] 1423-0380
  • [Journal-full-title] Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
  • [ISO-abbreviation] Tumour Biol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, Neoplasm; 0 / Biomarkers, Tumor; 0 / RNA, Messenger; 0 / Serpins; 0 / squamous cell carcinoma-related antigen
  • [Other-IDs] NLM/ PMC2953620
  •  go-up   go-down


31. Stegmeier F, Sowa ME, Nalepa G, Gygi SP, Harper JW, Elledge SJ: The tumor suppressor CYLD regulates entry into mitosis. Proc Natl Acad Sci U S A; 2007 May 22;104(21):8869-74
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The tumor suppressor CYLD regulates entry into mitosis.
  • Mutations in the cylindromatosis (CYLD) gene cause benign tumors of skin appendages, referred to as cylindromas.
  • The dysregulation of NF-kappaB activity has been proposed to promote cell transformation in part by increasing apoptosis resistance, but it is not clear whether this is CYLD's only or predominant tumor-suppressing function.
  • Our findings raise the possibility that, as with other genes regulating tumorigenesis, CYLD has not only tumor-suppressing (apoptosis regulation) but also tumor-promoting activities (enhancer of mitotic entry).
  • We propose that this additional function of CYLD could provide an explanation for the benign nature of most cylindroma lesions.
  • [MeSH-major] Mitosis. Tumor Suppressor Proteins / metabolism

  • COS Scholar Universe. author profiles.
  • Gene Ontology. gene/protein/disease-specific - Gene Ontology annotations from this paper .
  • Addgene Non-profit plasmid repository. clones/clone libraries - Get Article's Plasmids - Addgene (subscription/membership/fee required).
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • SciCrunch. OMIM: Data: Gene Annotation .
  • eagle-i research resources. PMID 17495026 (Special Collections) .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Nat Genet. 2000 Jun;25(2):160-5 [10835629.001]
  • [Cites] Nat Rev Mol Cell Biol. 2004 Jun;5(6):429-40 [15173822.001]
  • [Cites] Curr Opin Cell Biol. 2000 Dec;12(6):658-65 [11063929.001]
  • [Cites] Cell Growth Differ. 2000 Dec;11(12):615-23 [11149596.001]
  • [Cites] Mol Biol Cell. 2001 Jun;12(6):1791-9 [11408585.001]
  • [Cites] J Cell Biol. 2002 Jan 21;156(2):249-59 [11807090.001]
  • [Cites] Annu Rev Genet. 2002;36:617-56 [12429704.001]
  • [Cites] Nat Cell Biol. 2003 Apr;5(4):346-51 [12629549.001]
  • [Cites] Nat Cell Biol. 2003 Jun;5(6):545-51 [12766774.001]
  • [Cites] Nature. 2003 Aug 14;424(6950):793-6 [12917689.001]
  • [Cites] Nature. 2003 Aug 14;424(6950):797-801 [12917690.001]
  • [Cites] Nature. 2003 Aug 14;424(6950):801-5 [12917691.001]
  • [Cites] Curr Opin Cell Biol. 2004 Apr;16(2):119-26 [15196553.001]
  • [Cites] Chromosoma. 2004 Nov;113(5):211-22 [15351889.001]
  • [Cites] Cell. 1991 Mar 8;64(5):903-14 [1825803.001]
  • [Cites] Trends Biochem Sci. 1993 Mar;18(3):82-3 [8480366.001]
  • [Cites] J Med Genet. 1994 Apr;31(4):321-4 [8071959.001]
  • [Cites] Curr Opin Cell Biol. 1994 Dec;6(6):877-82 [7880537.001]
  • [Cites] Curr Opin Genet Dev. 1995 Feb;5(1):5-11 [7749325.001]
  • [Cites] Science. 1996 Sep 6;273(5280):1377-80 [8703070.001]
  • [Cites] Science. 1996 Dec 6;274(5293):1643-5 [8984634.001]
  • [Cites] Biochem Biophys Res Commun. 1997 Oct 20;239(2):377-85 [9344838.001]
  • [Cites] J Cell Sci. 1998 Jun;111 ( Pt 12):1751-7 [9601104.001]
  • [Cites] Science. 1998 Nov 27;282(5394):1701-4 [9831560.001]
  • [Cites] Curr Opin Cell Biol. 2004 Dec;16(6):623-8 [15530772.001]
  • [Cites] Nature. 2004 Nov 18;432(7015):316-23 [15549093.001]
  • [Cites] Mol Biol Cell. 2004 Dec;15(12):5623-34 [15469984.001]
  • [Cites] J Biol Chem. 2004 Dec 31;279(53):55161-7 [15496400.001]
  • [Cites] Science. 2005 Dec 2;310(5753):1499-504 [16322459.001]
  • [Cites] J Biol Chem. 2005 Dec 9;280(49):41111-21 [16230348.001]
  • [Cites] Trends Cell Biol. 2006 Jan;16(1):55-63 [16337124.001]
  • [Cites] Cell. 2006 May 19;125(4):665-77 [16713561.001]
  • [Cites] Nature. 2007 Apr 19;446(7138):876-81 [17443180.001]
  • [Cites] Nat Cell Biol. 2007 May;9(5):556-64 [17417629.001]
  • [Cites] Oncogene. 2003 Oct 16;22(46):7101-7 [14562038.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 May 25;101(21):7937-42 [15148369.001]
  • [Cites] Nature. 2000 Jul 27;406(6794):430-5 [10935642.001]
  • (PMID = 17495026.001).
  • [ISSN] 0027-8424
  • [Journal-full-title] Proceedings of the National Academy of Sciences of the United States of America
  • [ISO-abbreviation] Proc. Natl. Acad. Sci. U.S.A.
  • [Language] eng
  • [Grant] United States / NIA NIH HHS / AG / R01 AG011085
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / CYLD protein, human; 0 / NF-kappa B; 0 / Tumor Suppressor Proteins; 0 / ets-Domain Protein Elk-1
  • [Other-IDs] NLM/ PMC1867381
  •  go-up   go-down


32. Scheller K, Scheller C, Becker S, Holzhausen HJ, Schubert J: Cellular blue nevus (CBN) lymph node metastases of the neck with no primary skin lesion: a case report and review of literature. J Craniomaxillofac Surg; 2010 Dec;38(8):601-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cellular blue nevus (CBN) lymph node metastases of the neck with no primary skin lesion: a case report and review of literature.
  • A case of cervical lymph node infiltration by a benign cellular blue nevus (CBN) and a 27-year disease history is presented.
  • Dermal dendritic melanocytes and pigmented spindle cells presented no histological evidence of malignancy (CD34-, desmin-, PanCy-, HMB-45+, anti-S-100+, Bcl-2+, MART-1+, focally expression of melan A, 1% Ki-67+ of the tumour cell nucleoli).
  • The differentiation of the benign blue nevus (BN) from a malignant blue nevus (MBN) and a malignant melanoma (MM) is still a challenge.
  • [MeSH-major] Lymph Nodes / pathology. Nevus, Blue / pathology. Skin Neoplasms / pathology
  • [MeSH-minor] Diagnosis, Differential. Humans. Lymphatic Metastasis. Male. Melanoma / pathology. Middle Aged. Neck. Treatment Outcome

  • Genetic Alliance. consumer health - Nevus.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.
  • (PMID = 20223677.001).
  • [ISSN] 1878-4119
  • [Journal-full-title] Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery
  • [ISO-abbreviation] J Craniomaxillofac Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Scotland
  •  go-up   go-down


33. Bugatti L, Filosa G: Dermatoscopic features of cutaneous atypical fibroxanthoma: three cases. Clin Exp Dermatol; 2009 Dec;34(8):e898-900
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Dermatoscopic features of cutaneous atypical fibroxanthoma: three cases.
  • Atypical fibroxanthoma (AFX) is an uncommon, low-grade, malignant, spindle-cell tumour of fibrohistiocytic histogenesis, which can mimic other malignant skin tumours, such as basal and squamous cell carcinoma (CC), melanoma, and Merkel cell carcinoma (MCC).
  • AFX may be added to the list of slightly pigmented, reddish, malignant cutaneous tumours, such as SCC, MCC, amelanotic/hypomelanotic melanoma and eccrine porocarcinoma, which display prominent and chaotic dermatoscopic neoangiogenetic features in more advanced stages of proliferation.
  • [MeSH-major] Dermoscopy / methods. Histiocytoma, Benign Fibrous / pathology. Melanoma / pathology. Skin Neoplasms / pathology
  • [MeSH-minor] Aged. Aged, 80 and over. Diagnosis, Differential. Female. Humans. Male

  • MedlinePlus Health Information. consumer health - Melanoma.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20055861.001).
  • [ISSN] 1365-2230
  • [Journal-full-title] Clinical and experimental dermatology
  • [ISO-abbreviation] Clin. Exp. Dermatol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down


34. de Giorgi V, Sestini S, Massi D, Papi F, Lotti T: Atypical Spitz tumour: a 'chameleon' lesion. Clin Exp Dermatol; 2008 May;33(3):309-11
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Atypical Spitz tumour: a 'chameleon' lesion.
  • The term 'Spitz tumour' has been proposed for these lesions, as the term 'naevus' indicates a lesion that is completely benign and presents no risk to the patient.
  • We present a case of atypical Spitz tumour with peculiar atypical clinical and dermatoscopic features.
  • The difficulty in managing this Spitz tumour was aggravated by the clinical diagnosis.
  • In fact, the lesion appeared as a benign and nonmelanocytic lesion, a pigmented dermatofibroma.
  • The atypical Spitz tumour is a 'chameleon' lesion that can mimic not only melanocytic, but also nonmelanocytic lesions.
  • [MeSH-major] Melanoma / pathology. Nevus, Epithelioid and Spindle Cell / pathology. Pregnancy Complications, Neoplastic / pathology. Skin Neoplasms / pathology
  • [MeSH-minor] Adult. Diagnosis, Differential. Female. Humans. Hyperpigmentation / pathology. Melanocytes / pathology. Pregnancy. Risk Factors. Treatment Outcome


35. Persichetti P, Langella M, Cogliandro A, Marangi GF, Perrella E, Rabitti C, Mellone P, Baldi A: Cutaneous lymphoadenoma: a rare clinicopathological entity. J Exp Clin Cancer Res; 2005 Sep;24(3):497-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cutaneous lymphoadenoma: a rare clinicopathological entity.
  • Cutaneous Lymphadenoma (Benign Lymphoepithelial tumour of the skin) is a rare tumour, with distinctive clinical and histological features.
  • We present a case of cutaneous lymphoadenoma in a 52-year-old man and a short review of the literature, summarizing the principal clinical and morphological characteristics of this rare tumour.
  • [MeSH-major] Adenoma / diagnosis. Skin Neoplasms / diagnosis
  • [MeSH-minor] Carcinoma, Basal Cell / diagnosis. Carcinoma, Basal Cell / pathology. Humans. Male. Middle Aged

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16270539.001).
  • [ISSN] 0392-9078
  • [Journal-full-title] Journal of experimental & clinical cancer research : CR
  • [ISO-abbreviation] J. Exp. Clin. Cancer Res.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Italy
  •  go-up   go-down


36. Balik E, Eren T, Bugra D: A surgical approach to anogenital Buschke Loewenstein tumours (giant condyloma acuminata). Acta Chir Belg; 2009 Oct;109(5):612-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: The medical records of five patients, who had been surgically treated following the diagnosis of giant perianal condyloma acuminata between April, 1996 and September, 2003 were reviewed and evaluated retrospectively.
  • Full thickness tumour and skin excisions were performed followed by delayed split thickness skin graftings in all patients.
  • The wounds were left open for secondary healing, and following a mean time period of 35 days, split thickness skin graftings were performed.
  • CONCLUSIONS: Peri-anal condyloma acuminatum is usually a benign disease, but may grow locally to an excessive extent, developing into a Buschke Loewenstein Tumour, and may cause serious peri-anal hygiene problems.
  • [MeSH-minor] Adult. Female. Humans. Male. Middle Aged. Skin Transplantation. Wound Healing

  • MedlinePlus Health Information. consumer health - Anal Disorders.
  • MedlinePlus Health Information. consumer health - Genital Warts.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19994804.001).
  • [ISSN] 0001-5458
  • [Journal-full-title] Acta chirurgica Belgica
  • [ISO-abbreviation] Acta Chir. Belg.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Belgium
  •  go-up   go-down


37. Gaggioli C, Sahai E: Melanoma invasion - current knowledge and future directions. Pigment Cell Res; 2007 Jun;20(3):161-72
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The acquisition of invasive behaviour is the key transition in the progression of benign melanocyte hyperplasia to life threatening melanoma.

  • MedlinePlus Health Information. consumer health - Melanoma.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17516924.001).
  • [ISSN] 0893-5785
  • [Journal-full-title] Pigment cell research
  • [ISO-abbreviation] Pigment Cell Res.
  • [Language] ENG
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] Denmark
  • [Number-of-references] 120
  •  go-up   go-down


38. Rawal YB, Anderson KM, Rawal SY: Multinucleate cell angiohistiocytoma: an uncommon mucosal tumour. Clin Exp Dermatol; 2009 Apr;34(3):333-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Multinucleate cell angiohistiocytoma: an uncommon mucosal tumour.
  • Multinucleate cell angiohistiocytoma (MCAH) is an uncommon benign soft-tissue lesion with characteristic histological and immunohistochemical features.
  • It is unclear if it represents a benign neoplasm or a reactive/inflammatory process.
  • The overwhelming majority of these tumors have been described on cutaneous surfaces.
  • One case has been reported on the skin of the lip.
  • Because of the benign nature of this lesion, a conservative approach is recommended in its management.
  • [MeSH-major] Histiocytoma / pathology. Mouth Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Oral Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19040523.001).
  • [ISSN] 1365-2230
  • [Journal-full-title] Clinical and experimental dermatology
  • [ISO-abbreviation] Clin. Exp. Dermatol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down


39. Jakab C, Szász AM, Kulka J, Schaff Z, Rusvai M, Németh T, Gálfi P: Cutaneous mast cell tumour within a lipoma in a boxer. Acta Vet Hung; 2009 Jun;57(2):263-74
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cutaneous mast cell tumour within a lipoma in a boxer.
  • This report describes a case of a canine cutaneous grade I mast cell tumour which developed within a lipoma in the right axillar region of an 8-year-old male Boxer.
  • The proliferation index of the mast cell tumour based on the Ki-67 antigen was 6.1%.
  • Between the benign neoplastic lipocytes and mastocytoma tumour cells intratumoural microvessels were detected by immunohistochemical staining using CD31 and claudin-5 as markers for vascular endothelium.
  • [MeSH-major] Dog Diseases / pathology. Lipoma / veterinary. Mastocytoma / veterinary. Skin Neoplasms / veterinary

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19584039.001).
  • [ISSN] 0236-6290
  • [Journal-full-title] Acta veterinaria Hungarica
  • [ISO-abbreviation] Acta Vet. Hung.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Hungary
  •  go-up   go-down


40. Onuma K, Sato Y, Ogawara S, Shirasawa N, Kobayashi M, Yoshitake J, Yoshimura T, Iigo M, Fujii J, Okada F: Nano-scaled particles of titanium dioxide convert benign mouse fibrosarcoma cells into aggressive tumor cells. Am J Pathol; 2009 Nov;175(5):2171-83
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Nano-scaled particles of titanium dioxide convert benign mouse fibrosarcoma cells into aggressive tumor cells.
  • We found that mice that were cotransplanted subcutaneously with QR-32 cells and nano-sized TiO(2), either uncoated (TiO(2)-1, hydrophilic) or coated with stearic acid (TiO(2)-2, hydrophobic), did not form tumors.
  • However, QR-32 cells became tumorigenic after injection into sites previously implanted with TiO(2)-1, but not TiO(2)-2, and these developing tumors acquired metastatic phenotypes.
  • These results indicate that nano-sized TiO(2) has the potential to convert benign tumor cells into malignant ones through the generation of ROS in the target cells.
  • [MeSH-major] Cell Transformation, Neoplastic / drug effects. Fibrosarcoma. Nanoparticles / chemistry. Neoplasm Invasiveness. Titanium / pharmacology
  • [MeSH-minor] Animals. Cell Line, Tumor. Cytokines / genetics. Cytokines / metabolism. Deoxyguanosine / analogs & derivatives. Deoxyguanosine / metabolism. Dinoprostone / metabolism. Female. Intercellular Signaling Peptides and Proteins / genetics. Intercellular Signaling Peptides and Proteins / metabolism. Mice. Mice, Inbred C57BL. Particle Size. Reactive Oxygen Species / metabolism. Thymosin / genetics. Thymosin / metabolism. Vascular Endothelial Growth Factor A / metabolism

  • Hazardous Substances Data Bank. TITANIUM DIOXIDE .
  • Hazardous Substances Data Bank. TITANIUM .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Occup Med. 1988 Dec;30(12):937-42 [3230444.001]
  • [Cites] J Toxicol Environ Health. 1990;29(4):417-29 [2325155.001]
  • [Cites] Cancer Immunol Immunother. 1990;31(6):358-64 [2386981.001]
  • [Cites] Br J Cancer. 1992 Oct;66(4):635-9 [1419599.001]
  • [Cites] Br J Cancer. 1994 Aug;70(2):233-8 [8054271.001]
  • [Cites] J Immunol. 1996 Dec 15;157(12):5512-20 [8955201.001]
  • [Cites] J Biochem. 1997 Aug;122(2):459-66 [9378727.001]
  • [Cites] Br Med Bull. 1997;53(3):662-8 [9374044.001]
  • [Cites] FEBS Lett. 1997 Nov 24;418(1-2):87-90 [9414101.001]
  • [Cites] Exp Lung Res. 1998 Jan-Feb;24(1):85-100 [9457471.001]
  • [Cites] Am J Physiol. 1998 Jan;274(1 Pt 1):L81-6 [9458804.001]
  • [Cites] J Appl Toxicol. 1998 Sep-Oct;18(5):307-12 [9804429.001]
  • [Cites] Br J Cancer. 1999 Feb;79(3-4):377-85 [10027302.001]
  • [Cites] Skin Pharmacol Appl Skin Physiol. 1999 Sep-Oct;12(5):247-56 [10461093.001]
  • [Cites] FASEB J. 2005 Mar;19(3):311-30 [15746175.001]
  • [Cites] Exp Cell Res. 2005 Apr 15;305(1):51-62 [15777787.001]
  • [Cites] J Am Chem Soc. 2005 Mar 30;127(12):4388-96 [15783221.001]
  • [Cites] Environ Health Perspect. 2005 Jul;113(7):823-39 [16002369.001]
  • [Cites] Toxicology. 2005 Sep 15;213(1-2):66-73 [15970370.001]
  • [Cites] Environ Health Perspect. 2005 Nov;113(11):1555-60 [16263511.001]
  • [Cites] Nitric Oxide. 2006 Mar;14(2):122-9 [16125421.001]
  • [Cites] Environ Health Perspect. 2006 Mar;114(3):341-9 [16507455.001]
  • [Cites] Br J Cancer. 2006 Mar 27;94(6):854-62 [16508635.001]
  • [Cites] Lancet Oncol. 2006 Apr;7(4):295-6 [16598890.001]
  • [Cites] Am J Pathol. 2006 Jul;169(1):294-302 [16816381.001]
  • [Cites] FASEB J. 2006 Nov;20(13):2393-5 [17023518.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Dec 12;103(50):18882-6 [17135351.001]
  • [Cites] Toxicol Lett. 2007 Jan 10;168(1):58-74 [17141434.001]
  • [Cites] Proc Natl Acad Sci U S A. 2007 Feb 13;104(7):2029-30 [17284585.001]
  • [Cites] Water Sci Technol. 2006;54(11-12):327-34 [17302336.001]
  • [Cites] Mutat Res. 2007 Apr 2;628(2):99-106 [17223607.001]
  • [Cites] Biomaterials. 2007 Jul;28(19):2946-58 [17379299.001]
  • [Cites] Int J Cancer. 2007 Dec 1;121(11):2364-72 [17893867.001]
  • [Cites] Oncogene. 2008 Nov 27;27(56):7070-82 [18806824.001]
  • [Cites] Tumour Biol. 2000 Jan-Feb;21(1):11-20 [10601837.001]
  • [Cites] Toxicology. 2001 Aug 28;165(2-3):133-44 [11522371.001]
  • [Cites] Photochem Photobiol. 2001 Nov;74(5):656-69 [11723793.001]
  • [Cites] Am J Pathol. 2002 Mar;160(3):869-82 [11891186.001]
  • [Cites] Proc Nutr Soc. 2002 Feb;61(1):123-30 [12002786.001]
  • [Cites] Semin Oncol. 2002 Jun;29(3 Suppl 7):5-11 [12068382.001]
  • [Cites] Biomaterials. 2002 Sep;23(17):3757-64 [12109701.001]
  • [Cites] Toxicol In Vitro. 2002 Oct;16(5):629-35 [12206830.001]
  • [Cites] Environ Health Perspect. 2003 Apr;111(4):455-60 [12676598.001]
  • [Cites] J Biosci. 2003 Feb;28(1):51-5 [12682424.001]
  • [Cites] Pharmacol Ther. 2003 Jul;99(1):113-32 [12804702.001]
  • [Cites] Prog Lipid Res. 2003 Nov;42(6):463-78 [14559067.001]
  • [Cites] Am J Pathol. 2003 Dec;163(6):2221-32 [14633597.001]
  • [Cites] Am J Physiol Lung Cell Mol Physiol. 2004 Feb;286(2):L344-53 [14555462.001]
  • [Cites] Water Sci Technol. 2004;49(1):103-10 [14979544.001]
  • [Cites] Free Radic Biol Med. 2004 Oct 1;37(7):916-25 [15336307.001]
  • [Cites] J Nanosci Nanotechnol. 2004 May;4(5):521-31 [15503438.001]
  • [Cites] Proc Natl Acad Sci U S A. 1975 May;72(5):1848-51 [1057174.001]
  • [Cites] Ann N Y Acad Sci. 1976;276:455-65 [1071971.001]
  • [Cites] Int J Cancer. 1987 Mar 15;39(3):338-42 [2434441.001]
  • [Cites] Scand J Work Environ Health. 1987 Feb;13(1):47-51 [3495034.001]
  • (PMID = 19815711.001).
  • [ISSN] 1525-2191
  • [Journal-full-title] The American journal of pathology
  • [ISO-abbreviation] Am. J. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Cytokines; 0 / Intercellular Signaling Peptides and Proteins; 0 / Reactive Oxygen Species; 0 / Vascular Endothelial Growth Factor A; 15FIX9V2JP / titanium dioxide; 61512-21-8 / Thymosin; 77591-33-4 / thymosin beta(4); 88847-89-6 / 8-oxo-7-hydrodeoxyguanosine; D1JT611TNE / Titanium; G9481N71RO / Deoxyguanosine; K7Q1JQR04M / Dinoprostone
  • [Other-IDs] NLM/ PMC2774079
  •  go-up   go-down


41. Kaptanoglu AF, Kutluay L: Keratoacanthoma developing in previous cryotherapy site for solar keratosis. J Eur Acad Dermatol Venereol; 2006 Feb;20(2):197-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Keratoacanthoma developing in previous cryotherapy site for solar keratosis.
  • Keratoacanthoma is a relatively common benign squamous neoplasm that may show spontaneous clearing.
  • Although the cause of the tumour is unknown, there are some reports describing keratoacanthoma following various types of trauma or secondary to other skin lesions.
  • We report a rare case of keratoacanthoma arising in the site of cryotherapy applied for solar keratosis.
  • [MeSH-major] Cryotherapy / adverse effects. Keratoacanthoma / diagnosis. Skin Diseases / diagnosis
  • [MeSH-minor] Cicatrix / pathology. Diagnosis, Differential. Humans. Keratosis / surgery. Male. Middle Aged. Nose / pathology. Sunlight

  • Genetic Alliance. consumer health - Keratoacanthoma.
  • MedlinePlus Health Information. consumer health - Skin Conditions.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16441631.001).
  • [ISSN] 0926-9959
  • [Journal-full-title] Journal of the European Academy of Dermatology and Venereology : JEADV
  • [ISO-abbreviation] J Eur Acad Dermatol Venereol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


42. Cowen EW, Liu CW, Steinberg SM, Kang S, Vonderheid EC, Kwak HS, Booher S, Petricoin EF, Liotta LA, Whiteley G, Hwang ST: Differentiation of tumour-stage mycosis fungoides, psoriasis vulgaris and normal controls in a pilot study using serum proteomic analysis. Br J Dermatol; 2007 Nov;157(5):946-53
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Differentiation of tumour-stage mycosis fungoides, psoriasis vulgaris and normal controls in a pilot study using serum proteomic analysis.
  • The resultant 'proteomic signature' has been used to differentiate benign and malignant diseases, enable disease prognosis, and monitor response to therapy.
  • OBJECTIVES: This pilot study was designed to determine if serum protein patterns could be used to distinguish patients with tumour-stage mycosis fungoides (MF) from patients with a benign inflammatory skin condition (psoriasis) and/or subjects with healthy skin.
  • METHODS: Serum was analysed from 45 patients with tumour-stage MF, 56 patients with psoriasis, and 47 controls using two MS platforms of differing resolution.
  • CONCLUSIONS: Serum proteomics should be further investigated for its potential to identify patients with neoplastic skin disease and its ability to determine disease prognosis.
  • [MeSH-major] Blood Proteins / chemistry. Mycosis Fungoides / blood. Psoriasis / blood. Skin Neoplasms / blood


43. Miracco C, De Nisi MC, Arcuri F, Cosci E, Pacenti L, Toscano M, Lalinga AV, Biagioli M, Rubegni P, Vatti R, Maellaro E, Del Bello B, Massi D, Luzi P, Tosi P: Macrophage migration inhibitory factor protein and mRNA expression in cutaneous melanocytic tumours. Int J Oncol; 2006 Feb;28(2):345-52
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Macrophage migration inhibitory factor protein and mRNA expression in cutaneous melanocytic tumours.
  • Although MIF's functions in cancer have not been completely elucidated, its expression has usually been correlated with tumour progression and aggressiveness, and it is currently discussed as a new promising target for novel therapies.
  • We evaluated MIF protein expression in 126 skin lesions, including benign and atypical nevi, melanoma and melanoma metastases.
  • Benign nevi were subdivided into nevocytic and Spitz/blue types; and melanomas into the radial, and vertical growth phase.
  • All samples expressed MIF mRNA but it was significantly lower in benign nevi vs atypical nevi, melanomas and metastases (p=0.001; p<0.0001; p=0.002, respectively).
  • Whereas we observed a trend towards higher expression levels of mRNA in atypical and malignant tumours, MIF protein was highly expressed in all lesions, although limited to the cytoplasm in most benign nevi.
  • These observations suggest differences in MIF protein storage, subcellular location and properties in most benign nevi vs atypical and malignant tumours that should be confirmed by further investigation and correlation with clinical outcome.
  • [MeSH-major] Macrophage Migration-Inhibitory Factors / metabolism. Melanoma / metabolism. Nevus, Pigmented / metabolism. RNA, Messenger / metabolism. Skin Neoplasms / metabolism
  • [MeSH-minor] Cell Nucleus / metabolism. Cytoplasm / metabolism. Humans. Immunohistochemistry. Neoplasm Metastasis. Reverse Transcriptase Polymerase Chain Reaction

  • MedlinePlus Health Information. consumer health - Melanoma.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16391788.001).
  • [ISSN] 1019-6439
  • [Journal-full-title] International journal of oncology
  • [ISO-abbreviation] Int. J. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Greece
  • [Chemical-registry-number] 0 / Macrophage Migration-Inhibitory Factors; 0 / RNA, Messenger
  •  go-up   go-down


44. Litster AL, Sorenmo KU: Characterisation of the signalment, clinical and survival characteristics of 41 cats with mast cell neoplasia. J Feline Med Surg; 2006 Jun;8(3):177-83
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Characterisation of the signalment, clinical and survival characteristics of 41 cats with mast cell neoplasia.
  • Mast cell tumours (MCTs) are relatively common tumours of cats, and are the second most common cutaneous tumours in cats in the USA.
  • Signalment, clinical and survival characteristics of mast cell neoplasia were characterised in 41 cats.
  • The most common tumour location was cutaneous/subcutaneous head and trunk.
  • Stage 1a was the most common tumour stage at first diagnosis (n=20), followed by stage 4 (both stage 4a and stage 4b; n=10).
  • Of 22 cats that underwent excisional biopsy, mast cell neoplasia recurred in four cats during the study period.
  • Three of the 41 cats presented with simultaneous cutaneous and either splenic or lymph node tumours.
  • A comparison between cats with only cutaneous tumours (n=30) and those with tumours involving the spleen or lymph nodes (n=11) showed longer survival times for the cutaneous-only group (P=0.031).
  • Twelve of the 41 cats died of mast cell neoplasia during the study period.
  • When a subgroup of cats with only cutaneous tumours (no lymph node or visceral involvement) were divided according to whether there were multiple (five or more) tumours (n=6) or a single tumour (n=19), cats with single tumours survived longer than those with multiple tumours (P=0.001).
  • Solitary cutaneous feline MCTs without spread to the lymph nodes usually manifest as benign disease with a relatively protracted course.
  • However, multiple cutaneous tumours, recurrent tumours and primary splenic disease should receive a guarded prognosis due to the relatively short median survival times associated with these forms of the disease.
  • [MeSH-major] Cat Diseases / pathology. Mast-Cell Sarcoma / veterinary. Skin Neoplasms / veterinary
  • [MeSH-minor] Animals. Cats. Disease-Free Survival. Follow-Up Studies. Neoplasm Staging. Prognosis. Severity of Illness Index. Survival Analysis

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16476559.001).
  • [ISSN] 1098-612X
  • [Journal-full-title] Journal of feline medicine and surgery
  • [ISO-abbreviation] J. Feline Med. Surg.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


45. De Felice B, Wilson RR, Nacca M: Telomere shortening may be associated with human keloids. BMC Med Genet; 2009;10:110
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Keloids are benign skin tumors that are the effect of a dysregulated wound-healing process in genetically predisposed patients.
  • METHODS: We analyzed sample tissues were obtained from 20 patients with keloid skin lesions and normal skin was obtained from 20 healthy donors.
  • Using Terminal Restriction Fragment (TRF) analysis and Real-Time PCR assay, we detected a significant telomere shortening of 30% in keloid specimens compared to normal skin.
  • Moreover, an increase in ROS generation was detected in fibroblasts cell cultures from keloid specimens as more time elapsed compared to fibroblasts from normal skin.
  • Here we found increased ROS generation in fibroblasts from keloid fibroblasts cell cultures when compared to normal skin fibroblasts.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Ann N Y Acad Sci. 2000 Jun;908:99-110 [10911951.001]
  • [Cites] Mol Cell Biochem. 2009 Jul;327(1-2):191-201 [19224335.001]
  • [Cites] Crit Rev Oncol Hematol. 2002 Jan;41(1):29-40 [11796230.001]
  • [Cites] Nucleic Acids Res. 2002 May 15;30(10):e47 [12000852.001]
  • [Cites] Genes Chromosomes Cancer. 2002 Jul;34(3):269-75 [12007187.001]
  • [Cites] Trends Biochem Sci. 2002 Jul;27(7):339-44 [12114022.001]
  • [Cites] Hum Mol Genet. 2003 Feb 1;12(3):227-32 [12554677.001]
  • [Cites] Intern Med. 2003 Feb;42(2):150-3 [12636233.001]
  • [Cites] Arterioscler Thromb Vasc Biol. 2003 May 1;23(5):842-6 [12649083.001]
  • [Cites] Mol Cell Biol. 2003 Jul;23(13):4598-610 [12808100.001]
  • [Cites] Circ Res. 2004 Mar 19;94(5):575-84 [15031270.001]
  • [Cites] Circ Res. 2004 Apr 2;94(6):768-75 [14963003.001]
  • [Cites] Hypertens Res. 2004 May;27(5):319-25 [15198478.001]
  • [Cites] Am J Hum Genet. 1993 Apr;52(4):661-7 [8460632.001]
  • [Cites] Am J Pathol. 1994 Jul;145(1):105-13 [8030742.001]
  • [Cites] Science. 1995 Sep 1;269(5228):1236-41 [7544491.001]
  • [Cites] Hum Mol Genet. 1997 Jun;6(6):905-8 [9175737.001]
  • [Cites] Carcinogenesis. 2005 May;26(5):867-74 [15471900.001]
  • [Cites] J Dtsch Dermatol Ges. 2004 Nov;2(11):905-13 [16281608.001]
  • [Cites] Diabetes Care. 2006 Feb;29(2):283-9 [16443874.001]
  • [Cites] Aging Cell. 2006 Aug;5(4):325-30 [16913878.001]
  • [Cites] J Cell Sci. 2008 Apr 1;121(Pt 7):1046-53 [18334557.001]
  • [Cites] Br J Haematol. 2008 Jul;142(1):82-93 [18477050.001]
  • [Cites] Neoplasia. 2008 Oct;10(10):1131-7 [18813352.001]
  • [Cites] Plast Reconstr Surg. 2001 Mar;107(3):797-808 [11304607.001]
  • (PMID = 19863817.001).
  • [ISSN] 1471-2350
  • [Journal-full-title] BMC medical genetics
  • [ISO-abbreviation] BMC Med. Genet.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Reactive Oxygen Species; EC 2.7.7.49 / Telomerase
  • [Other-IDs] NLM/ PMC2774319
  •  go-up   go-down


46. Behroozan DS, Goldberg LH, Glaich AS, Kaplan B, Kaye VN: Mohs micrographic surgery for deeply penetrating, expanding benign cutaneous neoplasms. Dermatol Surg; 2006 Jul;32(7):958-65
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mohs micrographic surgery for deeply penetrating, expanding benign cutaneous neoplasms.
  • [MeSH-major] Mohs Surgery. Skin Neoplasms / surgery
  • [MeSH-minor] Adult. Carcinoma / pathology. Carcinoma / surgery. Carcinoma, Adenoid Cystic / pathology. Carcinoma, Adenoid Cystic / surgery. Epidermal Cyst / pathology. Epidermal Cyst / surgery. Female. Forehead / pathology. Granular Cell Tumor / pathology. Granular Cell Tumor / surgery. Heel / pathology. Humans. Male. Middle Aged. Neoplasm Metastasis. Nose / pathology. Pilomatrixoma / pathology. Pilomatrixoma / surgery. Scalp / pathology

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16875482.001).
  • [ISSN] 1076-0512
  • [Journal-full-title] Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
  • [ISO-abbreviation] Dermatol Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


47. Kuczkowski J, Izycka-Swieszewska E, Plichta Ł, Cieszyńska J: [Combined tumor of ceruminous gland origin in the external auditory canal--a histopathological and immunohistochemical study]. Otolaryngol Pol; 2010 Nov-Dec;64(6):385-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Combined tumor of ceruminous gland origin in the external auditory canal--a histopathological and immunohistochemical study].
  • OBJECTIVES: We present a case of a combined tumor consisting of solid tubular gland adenoma (TA) and syringocystadenoma papilliferum (SCAP) of the external auditory canal and review of the literature on this subject.
  • METHODS: Tumour of the external auditory canal was removed by retroauricular approach with good clinical outcome.
  • RESULTS: In the histopathological assessment tumour revealed an extraordinary combination of syringocystadenoma papilliferum and ceruminous tubular gland adenoma pattern.
  • CONCLUSIONS: Tubular gland adenoma and syringocystadenoma papilliferum are benign tumors originating from ceruminous glands of the skin, characterized by very rare occurrence especially in the skin of the external auditory canal.
  • Every tumor arising from the external auditory canal should be examined histologically and immunohistochemically in order to choose the best treatment option.
  • [MeSH-major] Adenoma / pathology. Cerumen. Ear Neoplasms / pathology. Ear, External / pathology. Sweat Gland Neoplasms / pathology
  • [MeSH-minor] Biomarkers, Tumor. Female. Humans. Immunohistochemistry. Middle Aged

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21302507.001).
  • [ISSN] 0030-6657
  • [Journal-full-title] Otolaryngologia polska = The Polish otolaryngology
  • [ISO-abbreviation] Otolaryngol Pol
  • [Language] pol
  • [Publication-type] Case Reports; English Abstract; Journal Article; Review
  • [Publication-country] Poland
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


48. Gönül M, Gul U, Gunduz H, Artantas S, Demiriz M: Disseminated lobular capillary hemangioma: two case reports. J Dermatol; 2005 Dec;32(12):996-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Lobular capillary hemangioma, also known as pyogenic granuloma, is a common, solitary, benign neoplasm of the skin and mucous membranes.
  • We report two cases of disseminated lobular capillary hemangioma without an associated disorder.
  • [MeSH-major] Granuloma, Pyogenic / pathology. Skin Diseases / pathology


49. Gerber PA, Schulte KW, Ruzicka T, Bruch-Gerharz D: Eccrine porocarcinoma of the head: an important differential diagnosis in the elderly patient. Dermatology; 2008;216(3):229-33
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Eccrine porocarcinoma of the head: an important differential diagnosis in the elderly patient.
  • BACKGROUND: Eccrine porocarcinoma is a rare malignant tumor of the sweat gland, characterized by a broad spectrum of clinicopathologic presentations.
  • Surprisingly, unlike its benign counterpart eccrine poroma, eccrine porocarcinoma is seldom found in areas with a high density of eccrine sweat glands, like the palms or soles.
  • Instead, eccrine porocarcinoma frequently occurs on the lower extremities, trunk and abdomen, but also on the head, resembling various other skin tumors, as illustrated in the patients described herein.
  • All patients were initially diagnosed as having epidermal or melanocytic skin tumors.
  • Only after histopathologic examination were they classified as eccrine porocarcinoma, showing features of epithelial tumors with abortive ductal differentiation.
  • Porocarcinomas are commonly overlooked, or misinterpreted as squamous or basal cell carcinomas as well as other common malignant and even benign skin tumors.
  • Knowledge of the clinical pattern and histologic findings, therefore, is crucial for an early therapeutic intervention, which can reduce the risk of tumor recurrence and serious complications.
  • [MeSH-major] Carcinoma, Skin Appendage / diagnosis. Eccrine Glands / pathology. Head and Neck Neoplasms / diagnosis. Sweat Gland Neoplasms / diagnosis
  • [MeSH-minor] Aged. Aged, 80 and over. Diagnosis, Differential. Diagnostic Errors. Female. Humans. Immunohistochemistry. Male. Middle Aged. Prognosis. Skin Neoplasms / diagnosis

  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18182815.001).
  • [ISSN] 1421-9832
  • [Journal-full-title] Dermatology (Basel, Switzerland)
  • [ISO-abbreviation] Dermatology (Basel)
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Switzerland
  •  go-up   go-down


50. Kerimoglu U, Aydingoz U, Ozkaya O, Aksu AE, Ergen FB: MRI of a benign chondroid syringoma. Br J Radiol; 2006 Aug;79(944):e59-61
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] MRI of a benign chondroid syringoma.
  • Chondroid syringoma, also known as mixed tumour of the skin, is a relatively rare, usually benign tumour.
  • A few malignant cases, especially in the lower extremities, have been published, but most of them behave in a benign fashion.
  • Despite rapid growth over a short period of time and a location reportedly associated with malignancy, the histological features were benign.
  • [MeSH-major] Adenoma, Pleomorphic / diagnosis. Sweat Gland Neoplasms / diagnosis
  • [MeSH-minor] Diagnosis, Differential. Female. Humans. Leg. Magnetic Resonance Imaging. Middle Aged

  • Genetic Alliance. consumer health - Syringoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16861320.001).
  • [ISSN] 1748-880X
  • [Journal-full-title] The British journal of radiology
  • [ISO-abbreviation] Br J Radiol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down


51. Grajkowska W, Kotulska K, Jurkiewicz E, Matyja E: Brain lesions in tuberous sclerosis complex. Review. Folia Neuropathol; 2010;48(3):139-49
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Tuberous sclerosis complex (TSC) is an autosomal dominant, multisystem disease characterized by the development of multiple hamartomas and benign or rarely malignant neoplasms distributed at various sites throughout the body, especially in the brain, skin, retina, kidney, heart, and lungs.
  • The clinical presentations of TSC result from mutations in either of two tumour suppressor genes: TSC1 (located on 9q34) or TSC2 (located on 16p13).
  • In this review, the clinicopathological features of TCS and recent advantages in the diagnosis and genetics of TSC are presented.


52. Eljamel MS: Robotic neurological surgery applications: accuracy and consistency or pure fantasy? Stereotact Funct Neurosurg; 2009;87(2):88-93
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We recruited 37 consecutive patients to test the application accuracy and consistency of the system using three different fiducial fixation mechanisms: a double adhesive fixed to the skin, an ECG lead dot fixed to the skin, and a registration plate fixed to the skull.
  • The procedures were: transsphenoidal in 8, malignant tumour biopsies in 3 and resections in 5, benign tumour excisions in 6 and functional procedures in 15 [6 bilateral deep-brain stimulations (DBSs) of the subthalamic nucleus for Parkinson's disease, 3 bilateral anterior cingulotomies for depression, 3 bilateral DBSs of the ventral intermediate nucleus of the thalamus for tremor and 3 depth electrodes during epilepsy surgery].
  • [MeSH-minor] Brain Neoplasms / surgery. Depressive Disorder / surgery. Female. Gyrus Cinguli / surgery. Humans. Male. Middle Aged. Parkinson Disease / surgery. Reproducibility of Results. Robotics / instrumentation. Robotics / methods. Robotics / standards. Software. Subthalamic Nucleus / surgery. Thalamic Nuclei / surgery

  • MedlinePlus Health Information. consumer health - Brain Diseases.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2009 S. Karger AG, Basel.
  • (PMID = 19223694.001).
  • [ISSN] 1423-0372
  • [Journal-full-title] Stereotactic and functional neurosurgery
  • [ISO-abbreviation] Stereotact Funct Neurosurg
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Technical Report; Validation Studies
  • [Publication-country] Switzerland
  •  go-up   go-down


53. Sevastre B, van Ederen AM, Terlou M, Gruys E, Nederbragt H: Immunohistochemical expression of tenascin in melanocytic tumours of dogs. J Comp Pathol; 2007 Jan;136(1):49-56
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The aim of this study was to investigate tenascin-C (TN) immunolabelling and labelling for endothelium by von Willebrand Factor (vWF) in melanocytic tumours of dogs as compared with normal tissues, to evaluate the TN distribution in these types of tumours and to investigate whether a relation could be established between TN and angiogenesis in different types of tumour.
  • Samples of normal dog skin (n=8), benign skin melanocytomas (n=10), malignant oral melanomas (n=9) and malignant toe melanomas (n=5) were studied.
  • In normal skin, TN was found at dermo-epidermal junctions, around hair follicles, in the smooth muscles of hair follicles, and in the walls of blood vessels.
  • TN immunolabelling (distribution and intensity) in melanocytomas was comparable with that found in normal skin.
  • In melanomas, TN was found in the connective tissue surrounding the tumour cell nests and in narrow stromal strands inside the tumour.
  • [MeSH-major] Biomarkers, Tumor / analysis. Dog Diseases / metabolism. Melanocytes / metabolism. Melanoma / metabolism. Melanoma / veterinary. Mouth Neoplasms / metabolism. Skin Neoplasms / metabolism. Skin Neoplasms / veterinary. Tenascin / metabolism
  • [MeSH-minor] Animals. Dogs. Immunohistochemistry. Skin / metabolism

  • MedlinePlus Health Information. consumer health - Melanoma.
  • MedlinePlus Health Information. consumer health - Oral Cancer.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17258226.001).
  • [ISSN] 0021-9975
  • [Journal-full-title] Journal of comparative pathology
  • [ISO-abbreviation] J. Comp. Pathol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Tenascin
  •  go-up   go-down


54. Abalo-Lojo JM, Cameselle-Teijeiro J, Gonzalez F: Pilomatrixoma: late onset in two periocular cases. Ophthal Plast Reconstr Surg; 2008 Jan-Feb;24(1):60-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • First described by Malherbe and Chenantais in 1880, pilomatrixoma is a benign skin neoplasm that arises from hair follicle matrix cells.
  • It is typically a tumor of younger individuals and rarely presents in older patients.
  • [MeSH-major] Eyelid Neoplasms / pathology. Hair Diseases / pathology. Pilomatrixoma / pathology. Skin Neoplasms / pathology

  • Genetic Alliance. consumer health - Pilomatrixoma.
  • MedlinePlus Health Information. consumer health - Hair Problems.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18209650.001).
  • [ISSN] 0740-9303
  • [Journal-full-title] Ophthalmic plastic and reconstructive surgery
  • [ISO-abbreviation] Ophthal Plast Reconstr Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


55. Heal C, Buettner P, Raasch B, Browning S: Minor skin excisions in general practice in North Queensland. Aust Fam Physician; 2006 Oct;35(10):825-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Minor skin excisions in general practice in North Queensland.
  • OBJECTIVE: To describe the demographics of patients presenting with skin cancer to general practitioners in rural North Queensland, the sites from which skin cancers are removed, and their histology.
  • METHODS: Data was recorded from 1247 consecutive patients who attended for minor skin lesion excisions.
  • RESULTS: Close to half (46.7%) of lesions excised were skin cancers.
  • Our number needed to treat (benign or dysplastic naevi excised per melanoma) was 8.4.
  • Relative tumour density was greatest in the face, scalp and neck region for all skin cancers.
  • DISCUSSION: In this sample of Mackay GPs, there was a very high yield of skin cancers from all excisions.
  • [MeSH-major] Carcinoma, Basal Cell / surgery. Carcinoma, Squamous Cell / surgery. Family Practice. Skin Neoplasms / surgery

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17019461.001).
  • [ISSN] 0300-8495
  • [Journal-full-title] Australian family physician
  • [ISO-abbreviation] Aust Fam Physician
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Australia
  •  go-up   go-down


56. Braun-Falco M: [Skin tumours of the facial area]. HNO; 2009 Apr;57(4):302-14
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Skin tumours of the facial area].
  • Almost the complete spectrum of skin tumours can occur within the facial area, ranging from benign tumours of infancy to typical malignancies of old age.
  • This spectrum is quiet heterogeneous and comprises every cell type within the skin as a possible origin for tumour growth.
  • Among these are cells derived from the epidermis; adnexal structures; connective, fatty, and vascular tissue; muscle; nerves; melanocytes; and skin-infiltrating inflammatory cells.
  • The present overview aims to summarise the basics of the most frequent and most important skin tumours occurring on the face.
  • [MeSH-major] Dermatology / trends. Facial Neoplasms / diagnosis. Facial Neoplasms / therapy. Otolaryngology / trends. Skin Neoplasms / diagnosis. Skin Neoplasms / therapy

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Strahlenther Onkol. 2001 May;177(5):240-6 [11398609.001]
  • [Cites] J Clin Pathol. 2007 Feb;60(2):145-59 [16882695.001]
  • [Cites] J Dtsch Dermatol Ges. 2006 Jul;4(7):586-90 [16827917.001]
  • [Cites] J Oral Maxillofac Surg. 2006 Jan;64(1):140-4 [16360873.001]
  • [Cites] Dermatol Surg. 2004 Feb;30(2 Pt 2):326-33; discussion 333 [14871228.001]
  • [Cites] Dermatol Surg. 2005 Nov;31(11 Pt 1):1379-84 [16416604.001]
  • [Cites] Am J Clin Oncol. 2006 Oct;29(5):524-8 [17023791.001]
  • [Cites] J Dtsch Dermatol Ges. 2006 Nov;4(11):982-3 [17081275.001]
  • [Cites] Hautarzt. 2006 Nov;57(11):988, 990-3 [17036250.001]
  • [Cites] Eur J Dermatol. 2006 Nov-Dec;16(6):599-606 [17229598.001]
  • [Cites] Pathologe. 2004 Feb;25(1):79-88 [14767616.001]
  • [Cites] J Dtsch Dermatol Ges. 2006 Jun;4(6):508-10 [16734843.001]
  • [Cites] J Am Acad Dermatol. 2007 Jun;56(6):989-93 [17504715.001]
  • [Cites] J Dtsch Dermatol Ges. 2007 Aug;5(8):662-8 [17659039.001]
  • [Cites] Hautarzt. 2004 Oct;55(10 ):991-4 [15635735.001]
  • [Cites] Hautarzt. 2007 May;58(5):412-8 [17429585.001]
  • [Cites] Dermatology. 2006;213(4):345-9 [17135744.001]
  • [Cites] Br J Dermatol. 2006 Apr;154(4):794-5 [16536841.001]
  • [Cites] Hautarzt. 2005 May;56(5):430-40 [15815888.001]
  • [Cites] Hautarzt. 2000 Apr;51(4):231-8 [10810657.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1446-53 [15817349.001]
  • [Cites] Blood. 2005 May 15;105(10):3768-85 [15692063.001]
  • [Cites] Br J Dermatol. 2005 Sep;153(3):653-6 [16120160.001]
  • [Cites] J Dtsch Dermatol Ges. 2005 Sep;3(9):710-20; quiz 721 [16173980.001]
  • [Cites] J Am Acad Dermatol. 1998 Jul;39(1):74-8 [9674400.001]
  • [Cites] Br J Dermatol. 2007 Jul;157(1):133-41 [17501955.001]
  • [Cites] Cochrane Database Syst Rev. 2007 Jan 24;(1):CD003412 [17253489.001]
  • [Cites] J Infect. 2001 Feb;42(2):134-9 [11531320.001]
  • [Cites] Dtsch Med Wochenschr. 2006 Mar 3;131(9):447-52 [16493570.001]
  • [Cites] Cancer J. 2005 May-Jun;11(3):241-7 [16053668.001]
  • [Cites] Cancer. 2007 Jul 1;110(1):1-12 [17520670.001]
  • [Cites] Hautarzt. 2004 Sep;55(9):841-54 [15316638.001]
  • [Cites] Br J Dermatol. 2007 Jul;157(1):87-91 [17501954.001]
  • [Cites] J Dtsch Dermatol Ges. 2007 Jul;5(7):605-17 [17610612.001]
  • [Cites] Hautarzt. 2007 Jul;58(7):577-84 [17522831.001]
  • [Cites] Hautarzt. 2005 Jul;56(7):679-82 [15726303.001]
  • [Cites] Hautarzt. 2001 Nov;52(11):1021-5 [11757456.001]
  • [Cites] Cancer. 1997 Mar 1;79(5):915-9 [9041153.001]
  • [Cites] J Am Acad Dermatol. 2000 Jan;42(1 Pt 2):23-4 [10607353.001]
  • [Cites] J Dtsch Dermatol Ges. 2006 Aug;4(8):686-97 [16895572.001]
  • [Cites] Hautarzt. 2006 Nov;57(11):975-84, 986-7 [17058053.001]
  • [Cites] Curr Opin Oncol. 2006 Sep;18(5):425-31 [16894288.001]
  • [Cites] Eur J Dermatol. 2007 Jul-Aug;17(4):332-4 [17540642.001]
  • [Cites] Acta Derm Venereol. 1991;71(2):134-7 [1675521.001]
  • [Cites] Hautarzt. 2003 Dec;54(12):1152-63 [14634744.001]
  • [Cites] J Dtsch Dermatol Ges. 2004 Aug;2(8):681-3 [16279231.001]
  • [Cites] Int J Dermatol. 2003 Dec;42(12):952-4 [14636191.001]
  • [Cites] J Eur Acad Dermatol Venereol. 2003 Mar;17(2):167-70 [12705745.001]
  • [Cites] Carcinogenesis. 2007 Mar;28(3):724-31 [17065198.001]
  • [Cites] J Dtsch Dermatol Ges. 2006 Jul;4(7):544-55 [16827912.001]
  • [Cites] Dermatol Surg. 2006 Apr;32(4):493-504 [16681656.001]
  • [Cites] Lancet Oncol. 2002 Mar;3(3):159-65 [11902502.001]
  • [Cites] J Clin Oncol. 2007 Mar 20;25(9):1043-7 [17369567.001]
  • [Cites] Br J Dermatol. 2005 Feb;152(2):361-4 [15727654.001]
  • [Cites] J Heart Lung Transplant. 2002 Nov;21(11):1201-5 [12431493.001]
  • [Cites] N Engl J Med. 2003 Apr 24;348(17):1681-91 [12711744.001]
  • [Cites] Int J Dermatol. 2007 Jan;46(1):12-8 [17214714.001]
  • [Cites] Am J Dermatopathol. 2002 Apr;24(2):166-8 [11979078.001]
  • [Cites] J Clin Pathol. 2007 Feb;60(2):129-44 [16882696.001]
  • [Cites] Arch Dermatol. 2006 Aug;142(8):976-82 [16924046.001]
  • [Cites] Cancer. 2003 Oct 15;98(8):1716-26 [14534889.001]
  • [Cites] J Am Acad Dermatol. 2005 Jan;52(1):92-100 [15627086.001]
  • [Cites] Hautarzt. 2003 Jun;54(6):551-60; quiz 561-2 [12858853.001]
  • [Cites] J Dtsch Dermatol Ges. 2006 Mar;4(3):260-2 [16626324.001]
  • [Cites] Arch Dermatol. 2003 Sep;139(9):1216-7 [12975172.001]
  • [Cites] J Clin Oncol. 2006 Jun 10;24(17):2644-52 [16763278.001]
  • [Cites] Hautarzt. 2007 Jul;58(7):597-603 [17579821.001]
  • [Cites] Hautarzt. 1990 Sep;41(9):513-4 [2249948.001]
  • [Cites] Pediatr Dermatol. 2006 Nov-Dec;23(6):574-9 [17156002.001]
  • [Cites] J Am Acad Dermatol. 2007 Aug;57(2):265-8 [17512087.001]
  • [Cites] Hautarzt. 2007 Aug;58(8):701-10, quiz 711 [17639284.001]
  • [Cites] J Clin Oncol. 2005 Apr 1;23(10):2300-9 [15800320.001]
  • [Cites] Br J Dermatol. 2003 Apr;148(4):703-8 [12752127.001]
  • [Cites] J Dtsch Dermatol Ges. 2006 May;4(5):441-3 [16686614.001]
  • [Cites] Postgrad Med J. 1997 Sep;73(863):538-42 [9373591.001]
  • [Cites] Hautarzt. 2006 Jun;57(6):537-48; quiz 549 [16752147.001]
  • [Cites] Hautarzt. 2007 May;58(5):406-11 [17440702.001]
  • [Cites] Cancer. 1987 Mar 1;59(5):1046-57 [3815265.001]
  • [Cites] Dtsch Med Wochenschr. 2004 Oct 15;129(42):2255-60 [15483764.001]
  • [Cites] J Dtsch Dermatol Ges. 2005 Oct;3(10):775-9 [16194155.001]
  • [Cites] J Dtsch Dermatol Ges. 2005 Dec;3(12):1009-15 [16416571.001]
  • [Cites] Br J Dermatol. 2002 Jul;147(1):41-7 [12100183.001]
  • [Cites] J Am Acad Dermatol. 2003 Jul;49(1):83-90 [12833014.001]
  • [Cites] J Dtsch Dermatol Ges. 2006 Apr;4(4):344-9 [16638065.001]
  • [Cites] Br J Dermatol. 2007 Jul;157(1):111-7 [17542980.001]
  • [Cites] J Dtsch Dermatol Ges. 2006 Jan;4(1):28-31 [16503928.001]
  • [Cites] J Invest Dermatol. 2000 Aug;115(2):273-7 [10951246.001]
  • [Cites] J Dtsch Dermatol Ges. 2006 Aug;4(8):684-5 [16895571.001]
  • [Cites] J Dtsch Dermatol Ges. 2007 Apr;5(4):334-8 [17376102.001]
  • [Cites] Hautarzt. 2005 Apr;56(4):353-8 [15580450.001]
  • [Cites] Ann Surg Oncol. 2001 Apr;8(3):204-8 [11314935.001]
  • [Cites] J Med Genet. 2005 Nov;42(11):801-10 [15958502.001]
  • [Cites] Hautarzt. 2001 Jul;52(7):649-52 [11475649.001]
  • [Cites] Hautarzt. 2007 May;58(5):419-26 [17443305.001]
  • [Cites] Br J Dermatol. 2002 Jun;146(6):1042-6 [12072074.001]
  • [Cites] Clin Med Res. 2006 Dec;4(4):273-93 [17210977.001]
  • [Cites] J Am Acad Dermatol. 2000 Jan;42(1 Pt 2):4-7 [10607349.001]
  • (PMID = 19322550.001).
  • [ISSN] 1433-0458
  • [Journal-full-title] HNO
  • [ISO-abbreviation] HNO
  • [Language] ger
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] Germany
  • [Number-of-references] 100
  •  go-up   go-down


57. Ettl T, Kleinheinz J, Mehrotra R, Schwarz S, Reichert TE, Driemel O: Infraorbital cutaneous angiosarcoma: a diagnostic and therapeutic dilemma. Head Face Med; 2008;4:18
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Infraorbital cutaneous angiosarcoma: a diagnostic and therapeutic dilemma.
  • BACKGROUND: A cutaneous angiosarcoma is a rare malignant tumour of vascular endothelial cells with aggressive clinical behaviour and poor prognosis.
  • Diagnosis is often delayed due to its variable and often benign clinical appearance.
  • Histopathologic examination of the specimen diagnosed a cutaneous angiosarcoma.
  • Neither, finally achieved negative margins on permanent sections, nor a following chemotherapy could prevent the recurrence of the disease after five months and the patient's dead 21 months after the first diagnosis.
  • [MeSH-major] Facial Neoplasms / pathology. Hemangiosarcoma / pathology. Neoplasm Recurrence, Local / pathology. Skin Neoplasms / pathology
  • [MeSH-minor] Biopsy, Needle. Chemotherapy, Adjuvant. Combined Modality Therapy. Disease Progression. Fatal Outcome. Humans. Immunohistochemistry. Male. Middle Aged. Neoplasm Staging. Radiotherapy, Adjuvant. Reoperation

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer. 2003 Nov 15;98(10):2251-6 [14601096.001]
  • [Cites] J Am Acad Dermatol. 2004 Jun;50(6):867-74 [15153886.001]
  • [Cites] Cancer. 1987 Mar 1;59(5):1046-57 [3815265.001]
  • [Cites] Am J Surg. 1990 Oct;160(4):365-9 [2221235.001]
  • [Cites] Am J Surg. 1994 Nov;168(5):451-4 [7977971.001]
  • [Cites] Cancer. 1995 Jul 15;76(2):319-27 [8625109.001]
  • [Cites] Cancer. 2003 Oct 15;98(8):1716-26 [14534889.001]
  • [Cites] Cancer. 2005 Jul 15;104(2):361-6 [15948172.001]
  • [Cites] Am J Clin Oncol. 2006 Oct;29(5):524-8 [17023791.001]
  • [Cites] Cancer. 1999 Nov 15;86(10):2034-7 [10570428.001]
  • [Cites] Am J Surg Pathol. 2001 Aug;25(8):1061-6 [11474291.001]
  • [Cites] J Eur Acad Dermatol Venereol. 2003 Sep;17(5):594-5 [12941106.001]
  • [Cites] J Am Acad Dermatol. 2003 Sep;49(3):530-1 [12963925.001]
  • [Cites] J Eur Acad Dermatol Venereol. 2005 May;19(3):357-9 [15857466.001]
  • (PMID = 18694495.001).
  • [ISSN] 1746-160X
  • [Journal-full-title] Head & face medicine
  • [ISO-abbreviation] Head Face Med
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2533304
  •  go-up   go-down


58. Pisacane AM, Risio M: VEGF and VEGFR-2 immunohistochemistry in human melanocytic naevi and cutaneous melanomas. Melanoma Res; 2005 Feb;15(1):39-43
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] VEGF and VEGFR-2 immunohistochemistry in human melanocytic naevi and cutaneous melanomas.
  • Vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor-2 (VEGFR-2) play a key role in vasculogenesis and angiogenic sprouting, which are crucial for tumour development and metastasis.
  • In order to determine their possible role in the acquisition of metastatic potential throughout melanocytic tumour progression, VEGF and VEGFR-2 immunohistochemical expression were evaluated in 36 human melanocytic tumours of the skin (24 malignant melanomas and 12 common naevi).
  • Taken together, these data indicate that VEGF production is a common event in benign melanocytic tumours, whereas VEGFR-2 expression, co-localized in the cytoplasmic and nuclear membrane, is associated with progression towards invasive melanoma.
  • The role exerted by VEGF/VEGFR-2, however, seems to be independent of the development of a tumour-related capillary network.
  • [MeSH-major] Biomarkers, Tumor / metabolism. Melanoma / metabolism. Nevus, Pigmented / metabolism. Skin Neoplasms / metabolism. Vascular Endothelial Growth Factor A / metabolism. Vascular Endothelial Growth Factor Receptor-2 / metabolism
  • [MeSH-minor] Cell Nucleus / metabolism. Cell Nucleus / pathology. Cytoplasm / metabolism. Cytoplasm / pathology. Humans. Immunoenzyme Techniques. Neoplasm Invasiveness

  • MedlinePlus Health Information. consumer health - Melanoma.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15714119.001).
  • [ISSN] 0960-8931
  • [Journal-full-title] Melanoma research
  • [ISO-abbreviation] Melanoma Res.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Vascular Endothelial Growth Factor A; EC 2.7.10.1 / Vascular Endothelial Growth Factor Receptor-2
  •  go-up   go-down


59. Schmidt JM, North SM, Freeman KP, Ramiro-Ibañez F: Feline paediatric oncology: retrospective assessment of 233 tumours from cats up to one year (1993 to 2008). J Small Anim Pract; 2010 Jun;51(6):306-11
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVES: To determine which types of tumour occur in cats up to the age of 12 months based on biopsies submitted to Idexx Laboratories, Wetherby, UK.
  • Tumours were categorised as haematopoietic (n=73, 31%), malignant epithelial (n=44; 19%), malignant mesenchymal (n=38; 16%), benign epithelial (n=37; 16%), benign mesenchymal (n=30, 13%) and miscellaneous (n=11; 5%).
  • The most frequent tumours were lymphoma (n=51; 22%), soft-tissue sarcoma (n=34; 15%), mast cell tumour (n=22; 9%) and squamous cell carcinoma (n=16; 7%).
  • The most common tumour site was the skin and soft tissues (41% of tumours).
  • In all, 164 neoplasms (70%) were malignant or had malignant potential.
  • [MeSH-major] Cat Diseases / pathology. Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20492453.001).
  • [ISSN] 1748-5827
  • [Journal-full-title] The Journal of small animal practice
  • [ISO-abbreviation] J Small Anim Pract
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


60. Wilsher M, Cheerala B: WT1 as a complementary marker of malignant melanoma: an immunohistochemical study of whole sections. Histopathology; 2007 Nov;51(5):605-10
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • AIMS: To test the usefulness of WT1 as a diagnostic aid in melanoma diagnosis and prognostication.
  • METHODS AND RESULTS: Benign naevi, Spitz naevi, dysplastic naevi and melanoma in situ, primary epithelioid, spindle cell and desmoplastic melanoma, and metastatic melanoma biopsy specimens were collected.
  • Primary melanoma cases were grouped using the 2003 Tumour Node Metastasis classification.
  • Benign naevi were uniformly negative with WT1.
  • CONCLUSIONS: WT1 is a useful ancillary diagnostic tool in routine melanoma diagnosis.
  • WT1 expression in primary melanoma is unrelated to tumour depth.
  • [MeSH-major] Biomarkers, Tumor / analysis. Melanoma / diagnosis. Skin Neoplasms / diagnosis. WT1 Proteins / analysis


61. Manganoni AM, Farisoglio C, Lonati A, Zorzi F, Tucci G, Pinton PG: Cutaneous epithelioid malignant schwannoma: review of the literature and case report. J Plast Reconstr Aesthet Surg; 2009 Sep;62(9):e318-21
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cutaneous epithelioid malignant schwannoma: review of the literature and case report.
  • A case of malignant epithelioid schwannoma in the skin is reported.
  • This was a rare variant of a malignant tumour that arose on the back of a 35-year-old male without neurofibromatosis.
  • Clinically the nodule appeared to be a benign cyst but as it was painful it was decided to remove it.
  • Most ordinary malignant schwannoma are located in the deep soft tissue of the proximal portions of the upper and lower extremities and trunk; to the best of our knowledge only 26 cases of malignant epithelioid schwannoma in the skin and subcutis have been described in the literature.
  • We can conclude that malignant epithelioid schwannoma in the skin and subcutis is eminently curable if treated with wide local excision.
  • [MeSH-major] Epithelioid Cells / pathology. Neurilemmoma / pathology. Skin / pathology. Skin Neoplasms / pathology

  • Genetic Alliance. consumer health - Schwannoma.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18455973.001).
  • [ISSN] 1878-0539
  • [Journal-full-title] Journal of plastic, reconstructive & aesthetic surgery : JPRAS
  • [ISO-abbreviation] J Plast Reconstr Aesthet Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Netherlands
  • [Number-of-references] 11
  •  go-up   go-down


62. Lucas A, Betlloch I, Planelles M, Martínez T, Pérez-Crespo M, Mataix J, Belinchón I: Non-melanocytic benign skin tumors in children. Am J Clin Dermatol; 2007;8(6):365-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Non-melanocytic benign skin tumors in children.
  • BACKGROUND: Dermatologists often attend children with benign skin tumors and cysts.
  • The decision to perform dermatologic surgery in children may be difficult to make, especially in cases of benign tumors.
  • OBJECTIVE: The objective of this study was to determine the nature of non-melanocytic benign skin tumors amenable to dermatologic surgery in children.
  • METHODS: Histopathologic studies of skin tumors in children treated by our department between January 2004 and December 2005 were studied.
  • Malignant and melanocytic tumors were excluded.
  • Age, sex, type of tumor, diagnostic category, site, size, reason for removal, type of anesthesia, and any other associated disorders were recorded.
  • RESULTS: The records revealed that 121 patients presented 129 non-melanocytic benign skin tumors (73 in boys and 56 in girls).
  • Tumors were located on the head and neck (45.7%), trunk (34.1%), and limbs (20.1%).
  • The reasons that led to removal of the tumors were: increase in the size of the tumor (49%); various types of discomfort, such as severe itching or pain (30%); parental concern (4%); diagnostic uncertainty (16%); and esthetic reasons (1%).
  • CONCLUSION: There is a wide diversity of non-melanocytic benign skin tumors in children, some of which require surgical treatment.
  • Pilomatrixomas appear to be the most frequent benign tumors; there are also high frequencies of infundibular cysts, pyogenic granulomas, and viral tumors.
  • [MeSH-major] Skin Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18039019.001).
  • [ISSN] 1175-0561
  • [Journal-full-title] American journal of clinical dermatology
  • [ISO-abbreviation] Am J Clin Dermatol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] New Zealand
  •  go-up   go-down


63. Badeloe S, Frank J: Clinical and molecular genetic aspects of hereditary multiple cutaneous leiomyomatosis. Eur J Dermatol; 2009 Nov-Dec;19(6):545-51
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Clinical and molecular genetic aspects of hereditary multiple cutaneous leiomyomatosis.
  • Multiple cutaneous and uterine leiomyomatosis syndrome (MCUL; OMIM 150800) is an autosomal dominantly inherited tumor predisposition disorder, characterized by leiomyomas of the skin and uterus.
  • Cutaneous leiomyoma can easily be recognized and confirmed by histological examination.
  • Recognition of these benign skin tumors can lead to the diagnosis of MCUL or HLRCC.
  • Timely diagnosis is crucial for offering affected individuals and families potentially life-saving regular prophylactic screening examinations for renal tumors.
  • Here we provide an overview of clinical and genetic features of this complex tumor syndrome and discuss patient management and current therapeutic strategies.
  • [MeSH-minor] Biomarkers / metabolism. Biopsy. Diagnosis, Differential. Female. Genetic Counseling. Genetic Predisposition to Disease. Humans. Kidney Neoplasms / genetics. Metabolism, Inborn Errors / genetics. Skin Neoplasms / genetics. Uterine Neoplasms / genetics

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19939761.001).
  • [ISSN] 1167-1122
  • [Journal-full-title] European journal of dermatology : EJD
  • [ISO-abbreviation] Eur J Dermatol
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] France
  • [Chemical-registry-number] 0 / Biomarkers; EC 4.2.1.2 / Fumarate Hydratase
  • [Number-of-references] 99
  •  go-up   go-down


64. Severi G, Shannon BA, Hoang HN, Baglietto L, English DR, Hopper JL, Pedersen J, Southey MC, Sinclair R, Cohen RJ, Giles GG: Plasma concentration of Propionibacterium acnes antibodies and prostate cancer risk: results from an Australian population-based case-control study. Br J Cancer; 2010 Jul 27;103(3):411-5
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Recent studies in prostatic tissue suggest that Propionibacterium acnes (P. acnes), a bacterium associated with acne that normally lives on the skin, is the most prevalent bacterium in the prostate and in men with benign prostatic hyperplasia.
  • The aim of our study was to test whether circulating levels of P. acnes antibodies are associated with prostate cancer risk and tumour characteristics using plasma samples from a population-based case-control study.
  • The primary analysis included P. acnes titres in the model as a dichotomous variable using the median value for controls as the cut-off value.
  • The association appeared to be particularly strong for advanced prostate cancer (AJCC Stage grouping III-IV) for which the odds ratio was 0.59 (95% CI 0.43-0.81, P=0.001) but there was insufficient evidence that the association differed by tumour stage (p heterogeneity=0.07).
  • [MeSH-major] Adenocarcinoma / epidemiology. Antibodies, Bacterial / blood. Propionibacterium acnes / immunology. Prostatic Neoplasms / epidemiology

  • Genetic Alliance. consumer health - Prostate cancer.
  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Int J Cancer. 2007 Dec 15;121(12):2688-92 [17724724.001]
  • [Cites] Med Hypotheses. 2007;69(4):960-1 [17056188.001]
  • [Cites] Immunol Rev. 2008 Apr;222:145-54 [18363999.001]
  • [Cites] Clin Cancer Res. 2008 Jun 1;14(11):3254-61 [18519750.001]
  • [Cites] Prostate. 2000 Sep 1;44(4):271-4 [10951490.001]
  • [Cites] Ann Oncol. 2001 Jun;12(6):761-5 [11484949.001]
  • [Cites] Int J Cancer. 2003 Jan 10;103(2):241-5 [12455039.001]
  • [Cites] J Natl Cancer Inst. 2003 Jun 4;95(11):818-24 [12783937.001]
  • [Cites] J Invest Dermatol. 2003 Nov;121(5):1226-8 [14708633.001]
  • [Cites] Immunology. 2004 Jul;112(3):352-63 [15196202.001]
  • [Cites] Ann Epidemiol. 2004 Oct;14(9):655-62 [15380796.001]
  • [Cites] Br J Dermatol. 1987 Jun;116(6):805-12 [2956986.001]
  • [Cites] Br J Urol. 1990 Jun;65(6):606-10 [1695535.001]
  • [Cites] J Urol. 2005 Jun;173(6):1969-74 [15879794.001]
  • [Cites] Am J Epidemiol. 2005 Jun 15;161(12):1094-101 [15937017.001]
  • [Cites] Cancer Causes Control. 2006 Nov;17(9):1127-33 [17006718.001]
  • [Cites] Scand J Immunol. 2007 Jun;65(6):538-48 [17523946.001]
  • [Cites] Front Biosci. 2007;12:4957-71 [17569623.001]
  • [Cites] BJU Int. 2008 Feb;101(4):429-35 [17850358.001]
  • (PMID = 20606679.001).
  • [ISSN] 1532-1827
  • [Journal-full-title] British journal of cancer
  • [ISO-abbreviation] Br. J. Cancer
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antibodies, Bacterial
  • [Other-IDs] NLM/ PMC2920014
  •  go-up   go-down


65. Alexis AF, Sergay AB, Taylor SC: Common dermatologic disorders in skin of color: a comparative practice survey. Cutis; 2007 Nov;80(5):387-94
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Common dermatologic disorders in skin of color: a comparative practice survey.
  • There is a paucity of data on the epidemiology of dermatologic disease in populations with skin of color.
  • We reviewed the diagnosis codes of 1412 patient visits from August 2004 through July 2005 at the Skin of Color Center at St. Luke's-Roosevelt Hospital Center, in New York.
  • During visits by black patients, the 5 most common diagnoses observed at our center were acne (ICD-9 [International Classification of Diseases, Ninth Revision] 706.1); dyschromia (ICD-9 709.09); contact dermatitis and other eczema, unspecified cause (ICD-9 692.9); alopecia (ICD-9 704.0); and seborrheic dermatitis (ICD-9 690.1).
  • During visits by white patients, the 5 most common diagnoses recorded were acne (ICD-9 706.1); lesion of unspecified behavior (ICD-9 238.2); benign neoplasm of skin of trunk (ICD-9 216.5); contact dermatitis and other eczema, unspecified cause (ICD-9 692.9); and psoriasis (ICD-9 696. 1).
  • [MeSH-major] Skin Diseases / diagnosis. Skin Diseases / ethnology
  • [MeSH-minor] Acne Vulgaris / diagnosis. Acne Vulgaris / ethnology. African Continental Ancestry Group. Dermatitis, Contact / diagnosis. Dermatitis, Contact / ethnology. Dermatitis, Seborrheic / diagnosis. Dermatitis, Seborrheic / ethnology. Eczema / diagnosis. Eczema / ethnology. European Continental Ancestry Group. Humans. Psoriasis / diagnosis. Psoriasis / ethnology. Retrospective Studies. Skin Neoplasms / diagnosis. Skin Neoplasms / ethnology

  • MedlinePlus Health Information. consumer health - Skin Conditions.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18189024.001).
  • [ISSN] 0011-4162
  • [Journal-full-title] Cutis
  • [ISO-abbreviation] Cutis
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


66. Muneer A, Laghari ZH, Shaikh AR, Laghari QA: Gynaecomastia: management in a developing country. J Ayub Med Coll Abbottabad; 2009 Jul-Sep;21(3):7-11
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Gynaecomastia is a benign enlargement of male breast.
  • Other causes were liver cirrhosis in 4 cases, testicular tumour in two, thyrotoxicosis in one and drug induced (use of cimetidine and Kushta) in two.
  • Most of the patients had bilateral, non tender lump in the breast.
  • Subcutaneous mastectomy through a periareolar skin incision is a valid procedure for treatment for gynaecomastia and provides satisfactory cosmetic results.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20929002.001).
  • [ISSN] 1025-9589
  • [Journal-full-title] Journal of Ayub Medical College, Abbottabad : JAMC
  • [ISO-abbreviation] J Ayub Med Coll Abbottabad
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Pakistan
  •  go-up   go-down


67. Aoyagi S, Izumi K, Hata H, Kawasaki H, Shimizu H: Usefulness of real-time tissue elastography for detecting lymph-node metastases in squamous cell carcinoma. Clin Exp Dermatol; 2009 Dec;34(8):e744-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Histologically, the metastatic tumour cells were located asymmetrically in a small section of the cortical area of the right node, and this result was comparable with the elastographic findings.
  • It has high predictive values in the differentiation of benign and malignant superficial lymph nodes in patients with clinically node-negative skin cancer.
  • More cases are needed to validate this efficiency in differentiating benign from malignant lymph-node status, but if confirmed, it may have an important role in the diagnosis of high-risk cutaneous squamous cell carcinoma.
  • [MeSH-major] Bowen's Disease / pathology. Carcinoma, Squamous Cell / secondary. Skin Neoplasms / pathology
  • [MeSH-minor] Aged, 80 and over. Elasticity Imaging Techniques. Female. Humans. Lymphatic Metastasis. Neoplasm Staging


68. Hsieh TJ, Wang CK, Tsai KB, Chen YW: Pilomatricoma: magnetic resonance imaging and pathological evaluation. J Comput Assist Tomogr; 2008 Mar-Apr;32(2):320-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Pilomatricoma is an asymptomatic, slowly growing, benign skin tumor that is typically located in the regions of head and neck.
  • Our case revealed late enhancement in the dynamic magnetic resonance imaging study that is a common pattern more in a benign soft tissue tumor and caused dramatic uptake in the bone scintigraphy.
  • [MeSH-major] Hair Diseases / diagnosis. Magnetic Resonance Imaging / methods. Pilomatrixoma / diagnosis. Skin Neoplasms / diagnosis

  • MedlinePlus Health Information. consumer health - Hair Problems.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18379325.001).
  • [ISSN] 0363-8715
  • [Journal-full-title] Journal of computer assisted tomography
  • [ISO-abbreviation] J Comput Assist Tomogr
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


69. Yang HJ, Yang KC: A new method for facial epidermoid cyst removal with minimal incision. J Eur Acad Dermatol Venereol; 2009 Aug;23(8):887-90
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Facial epidermoid cyst is a common benign epithelial tumour frequently seen in young or middle-aged people and may cause aesthetic disability.
  • The skin above the epidermoid cysts was infiltrated with local 0.1-cc 1% xylocaine anaesthetic by using a 26-gauge needle first, then 3-mm incisions were made with a No.11 surgical blade.
  • [MeSH-major] Epidermal Cyst / surgery. Minimally Invasive Surgical Procedures / methods. Skin Diseases / surgery

  • MedlinePlus Health Information. consumer health - Skin Conditions.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19453795.001).
  • [ISSN] 1468-3083
  • [Journal-full-title] Journal of the European Academy of Dermatology and Venereology : JEADV
  • [ISO-abbreviation] J Eur Acad Dermatol Venereol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


70. Chaudhry IH, Calonje E: Dermal non-neural granular cell tumour (so-called primitive polypoid granular cell tumour): a distinctive entity further delineated in a clinicopathological study of 11 cases. Histopathology; 2005 Aug;47(2):179-85
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Dermal non-neural granular cell tumour (so-called primitive polypoid granular cell tumour): a distinctive entity further delineated in a clinicopathological study of 11 cases.
  • AIMS: Cutaneous and soft tissue granular cell tumour is a well-characterized benign neoplasm of neural origin.
  • However, there remains a subcategory of granular cell tumour, first described by Le Boit as 'primitive polypoid granular cell tumour', that shows no obvious line of differentiation.
  • METHODS AND RESULTS: Eleven cases of dermal non-neural granular cell tumour were retrieved from one of the authors referral archives (E.C.) and both the histology and immunohistochemistry reviewed.
  • The tumours were composed of elongated spindle-shaped to polygonal or round cells with prominent granular cell change, and tumour nuclei showing mild focal atypia to rare moderate atypia.
  • Immunohistochemical labelling of the tumour cells demonstrated expression for NKI-C3 (n = 11), focal, weak positivity for CD68 (n = 10) and FXIIIa (n = 2).
  • [MeSH-major] Granular Cell Tumor / pathology. Skin Neoplasms / pathology
  • [MeSH-minor] Adolescent. Adult. Antigens, CD / analysis. Antigens, Differentiation, Myelomonocytic / analysis. Biomarkers, Tumor / analysis. Child. Factor XIIIa / analysis. Female. Humans. Immunohistochemistry. Lysosomes / immunology. Male. Middle Aged

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16045779.001).
  • [ISSN] 0309-0167
  • [Journal-full-title] Histopathology
  • [ISO-abbreviation] Histopathology
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antigens, CD; 0 / Antigens, Differentiation, Myelomonocytic; 0 / Biomarkers, Tumor; 0 / CD68 antigen, human; EC 2.3.2.13 / Factor XIIIa
  •  go-up   go-down


71. Ponnamperuma RM, King KE, Elsir T, Glick AB, Wahl GM, Nister M, Weinberg WC: The transcriptional regulatory function of p53 is essential for suppression of mouse skin carcinogenesis and can be dissociated from effects on TGF-beta-mediated growth regulation. J Pathol; 2009 Oct;219(2):263-74
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The transcriptional regulatory function of p53 is essential for suppression of mouse skin carcinogenesis and can be dissociated from effects on TGF-beta-mediated growth regulation.
  • Transcriptional regulation by p53 is critical for p53-mediated tumour suppression; however, p53-mediated transactivation has been dissociated from p53-mediated biological processes including apoptosis, DNA repair, and differentiation.
  • We applied in vitro endpoints correlated with epithelial tumourigenesis and an in vivo assay of tumour phenotype to assess whether loss of p53-mediated transcriptional regulation underlies the malignant phenotype of p53(-/-)/v-ras(Ha)-overexpressing keratinocytes.
  • The p53(QS - val135) allele did not confer a dominant-negative phenotype, as p53(+/QS - val135) keratinocytes senesced normally in response to v-ras(Ha) expression and formed benign tumours.
  • These findings support an essential role for p53-mediated transcriptional regulation in suppressing malignancies arising from ras-induced skin tumours, consistent with previous findings in spontaneous carcinogenesis in other organs, and highlight the potential importance of senescence for tumour suppression in vivo.

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • KOMP Repository. gene/protein/disease-specific - KOMP Repository (subscription/membership/fee required).
  • Mouse Genome Informatics (MGI). Mouse Genome Informatics (MGI) .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] 2009 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
  • [Cites] Oncogene. 2000 Mar 23;19(13):1698-709 [10763827.001]
  • [Cites] Proc Natl Acad Sci U S A. 2008 Jan 29;105(4):1215-20 [18216268.001]
  • [Cites] EMBO J. 2000 Sep 15;19(18):4967-75 [10990460.001]
  • [Cites] Cell Growth Differ. 2000 Nov;11(11):561-71 [11095245.001]
  • [Cites] Nat Med. 2002 Mar;8(3):282-8 [11875500.001]
  • [Cites] Biochimie. 2002 Jan;84(1):83-93 [11900880.001]
  • [Cites] Nat Genet. 2003 Mar;33(3):357-65 [12567188.001]
  • [Cites] Mol Cell. 2003 Mar;11(3):577-90 [12667443.001]
  • [Cites] Cell. 2003 May 2;113(3):301-14 [12732139.001]
  • [Cites] Cancer Res. 2003 May 15;63(10):2596-605 [12750285.001]
  • [Cites] Oncogene. 2003 Jun 5;22(23):3635-44 [12789272.001]
  • [Cites] Cancer Biol Ther. 2003 Jul-Aug;2(4 Suppl 1):S55-63 [14508081.001]
  • [Cites] Science. 2004 Feb 6;303(5659):844-8 [14704432.001]
  • [Cites] Trends Genet. 2004 Jun;20(6):235-43 [15145576.001]
  • [Cites] Nature. 1986 Oct 30-Nov 5;323(6091):822-4 [2430189.001]
  • [Cites] Cell. 1989 Jun 30;57(7):1083-93 [2525423.001]
  • [Cites] Cell. 1990 Aug 24;62(4):671-80 [2143698.001]
  • [Cites] Genes Dev. 1991 Feb;5(2):151-9 [1995413.001]
  • [Cites] Nature. 1992 Mar 19;356(6366):215-21 [1552940.001]
  • [Cites] Science. 1992 May 8;256(5058):827-30 [1589764.001]
  • [Cites] Cell. 1993 Sep 10;74(5):813-22 [8374952.001]
  • [Cites] Cancer Res. 1994 Nov 1;54(21):5584-92 [7923201.001]
  • [Cites] Genes Dev. 1994 Oct 15;8(20):2429-40 [7958907.001]
  • [Cites] Nat Genet. 1995 Mar;9(3):305-11 [7773294.001]
  • [Cites] Oncogene. 1995 Jun 15;10(12):2271-9 [7784075.001]
  • [Cites] Proc Natl Acad Sci U S A. 1995 Sep 26;92(20):9363-7 [7568133.001]
  • [Cites] Oncogene. 1997 May 29;14(21):2511-20 [9191051.001]
  • [Cites] Oncogene. 1997 Aug 7;15(6):685-90 [9264409.001]
  • [Cites] Mol Carcinog. 1998 Jan;21(1):50-61 [9473771.001]
  • [Cites] J Biol Chem. 1998 May 22;273(21):13030-6 [9582339.001]
  • [Cites] Oncogene. 1999 Mar 25;18(12):2149-55 [10321740.001]
  • [Cites] Curr Opin Oncol. 2005 Jan;17(1):49-54 [15608513.001]
  • [Cites] Nat Genet. 2005 Feb;37(2):145-52 [15654339.001]
  • [Cites] Oncogene. 2005 May 19;24(22):3563-73 [15750633.001]
  • [Cites] Expert Opin Biol Ther. 2006 Jan;6(1):55-61 [16370914.001]
  • [Cites] Cancer Res. 2006 Mar 15;66(6):2881-4 [16540631.001]
  • [Cites] Nat Genet. 2006 Apr;38(4):395-6; author reply 396-7 [16570054.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Jun 13;103(24):9051-6 [16757565.001]
  • [Cites] Science. 2007 Feb 9;315(5813):840-3 [17234915.001]
  • [Cites] Mol Cell Biol. 2007 Dec;27(23):8228-42 [17875924.001]
  • [Cites] Nat Genet. 2000 Sep;26(1):37-43 [10973245.001]
  • (PMID = 19718706.001).
  • [ISSN] 1096-9896
  • [Journal-full-title] The Journal of pathology
  • [ISO-abbreviation] J. Pathol.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / R01 CA100845; United States / NCI NIH HHS / CA / R01 CA100845-05; United States / FDA HHS / BO / Z01 BO04006-06
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Transforming Growth Factor beta; 0 / Tumor Suppressor Protein p53
  • [Other-IDs] NLM/ NIHMS146961; NLM/ PMC4208754
  •  go-up   go-down


72. Demirseren ME, Afandiyev K, Ceran C: Reconstruction of the perioral and perinasal defects with facial artery perforator flaps. J Plast Reconstr Aesthet Surg; 2009 Dec;62(12):1616-20
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Twelve clinical cases with 14 perioral and perinasal skin defects resulting from malignant or benign skin tumour excision were reconstructed using facial artery perforator flaps.
  • The donor-site scars were designed parallel to the facial wrinkles when possible.
  • The aesthetically pleasing donor site based on the facial artery perforators offers a versatile tailor-made flap, because of the reliable presence of perforators, with a large arc of rotation.
  • [MeSH-major] Head and Neck Neoplasms / surgery. Reconstructive Surgical Procedures / methods. Skin Neoplasms / surgery. Surgical Flaps / blood supply
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Carcinoma, Basal Cell / pathology. Carcinoma, Basal Cell / surgery. Esthetics. Face / blood supply. Female. Humans. Male. Middle Aged. Mouth Neoplasms / pathology. Mouth Neoplasms / surgery. Nose Neoplasms / pathology. Nose Neoplasms / surgery. Treatment Outcome


73. Wygledowska-Kania M, Kamińska-Winciorek G, Krauze E, Brzezińska-Wcisło L, Kajor M: Multifocal type of pilomatrixoma. Adv Med Sci; 2007;52:251-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Pilomatrixoma is a benign skin neoplasm that arises from hair follicle matrix cells.
  • The skin lesion occurs usually as a solitary tumor and the multifocal types are very rare.
  • Skin changes can be described as a firm to hard, non-painful, oval-shaped tumor that is covered by normal skin.
  • In this paper case of 16-years-old male patient with many solid tumors in subcutaneous tissue on both arms will be reported.
  • The first skin lesion appeared on the left arm 6 years ago.
  • Histopathological test has proved the clinical diagnosis of pilomatrixoma.
  • [MeSH-major] Pilomatrixoma / diagnosis. Skin Neoplasms / diagnosis
  • [MeSH-minor] Adolescent. Cicatrix / diagnosis. Diagnosis, Differential. Humans. Immunohistochemistry / methods. Inflammation. Male. Treatment Outcome

  • Genetic Alliance. consumer health - Pilomatrixoma.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18217427.001).
  • [ISSN] 1896-1126
  • [Journal-full-title] Advances in medical sciences
  • [ISO-abbreviation] Adv Med Sci
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Poland
  •  go-up   go-down


74. Tey HL, Chong WS, Wong SN: Leprosy-associated eccrine syringofibroadenoma of Mascaro. Clin Exp Dermatol; 2007 Sep;32(5):533-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Eccrine syringofibroadenoma of Mascaro is a rare benign tumour.
  • [MeSH-major] Adenoma, Sweat Gland / pathology. Eccrine Glands / pathology. Fibroadenoma / pathology. Leprosy, Lepromatous / complications. Skin Neoplasms / pathology. Sweat Gland Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17459067.001).
  • [ISSN] 0307-6938
  • [Journal-full-title] Clinical and experimental dermatology
  • [ISO-abbreviation] Clin. Exp. Dermatol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down


75. Repertinger S, Wang J, Adickes E, Sarma DP: Melanoma in-situ arising in seborrheic keratosis: a case report. Cases J; 2008;1(1):263
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Seborrheic keratosis is a very common benign skin tumor in man.
  • Melanoma is rare but is the most dreaded of all malignant skin tumors.
  • CASE PRESENTATION: An-86-year-old male with a history of multiple actinic keratoses and seborrheic keratoses of the head and trunk presented with a mid-back skin lesion.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Australas J Dermatol. 2006 May;47(2):109-13 [16637806.001]
  • [Cites] J Am Acad Dermatol. 2000 May;42(5 Pt 1):831-3 [10775864.001]
  • [Cites] Dermatol Surg. 2004 Apr;30(4 Pt 1):559-61 [15056152.001]
  • [Cites] Am J Dermatopathol. 1996 Jun;18(3):278-82 [8806962.001]
  • (PMID = 18947402.001).
  • [ISSN] 1757-1626
  • [Journal-full-title] Cases journal
  • [ISO-abbreviation] Cases J
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2577645
  •  go-up   go-down


76. Arrabal-Polo MA, Arias-Santiago SA, Aneiros-Fernandez J, Burkhardt-Perez P, Arrabal-Martin M, Naranjo-Sintes R: Cutaneous metastases in renal cell carcinoma: a case report. Cases J; 2009;2:7948
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cutaneous metastases in renal cell carcinoma: a case report.
  • Renal cell carcinoma is the most common form of malignant renal tumour and is extremely lethal.
  • About 25% of the patients develop metastasis at the time of diagnosis, and in many cases during the course of the disease, affecting the lung, lymphatic ganglions, liver, and bone, with skin metastases being quite rare.A 73-year-old patient, who had undergone surgery for adenocarcinoma in the left kidney 10 years previously, visited the dermatological service due to the appearance of recent, rapidly-developing lesion at the back of his neck.
  • Treatment with a multikinase angiogenesis inhibitor (sunitib) was started.Due to the late development of the skin metastases and those in other regions that worsen the prognosis, these patients must be subjected to long-term clinical observation.
  • Urologist should pay attention to cutaneous lesion appearing in these patients as in many times they look like benign lesion.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Cancer Res Clin Oncol. 1988;114(6):605-12 [3204107.001]
  • [Cites] J Urol. 1994 Dec;152(6 Pt 1):2094-5 [7966685.001]
  • [Cites] Urol Int. 1999;63(3):164-7 [10738187.001]
  • [Cites] Anticancer Res. 2000 May-Jun;20(3B):1939-40 [10928130.001]
  • [Cites] Dermatol Online J. 2007;13(4):6 [18319003.001]
  • [Cites] Int J Urol. 2005 Apr;12(4):401-4 [15948730.001]
  • [Cites] Int Semin Surg Oncol. 2006;3:27 [16968548.001]
  • [Cites] J Cutan Pathol. 2007 May;34(5):381-5 [17448192.001]
  • [Cites] Urol Int. 2008;80(1):111-2 [18204246.001]
  • [Cites] Arch Esp Urol. 2005 Apr;58(3):247-50 [15906619.001]
  • (PMID = 19918439.001).
  • [ISSN] 1757-1626
  • [Journal-full-title] Cases journal
  • [ISO-abbreviation] Cases J
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2769389
  •  go-up   go-down


77. Al-Za'abi AM, Ghazarian D, Greenberg GR, Shaw JC: Eruptive tufted angiomas in a patient with Crohn's disease. J Clin Pathol; 2005 Feb;58(2):214-6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Angioblastoma is a rare, benign vascular tumour composed of undifferentiated mesenchymal cells with a tendency to form lumina.
  • [MeSH-major] Crohn Disease / pathology. Hemangioma / pathology. Skin Neoplasms / pathology
  • [MeSH-minor] Adult. Antibodies, Monoclonal / administration & dosage. Gastrointestinal Agents / administration & dosage. Humans. Immunocompromised Host. Infliximab. Injections, Intravenous. Male. Neoplasm Regression, Spontaneous

  • Genetic Alliance. consumer health - Crohn Disease.
  • MedlinePlus Health Information. consumer health - Birthmarks.
  • MedlinePlus Health Information. consumer health - Crohn's Disease.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • Hazardous Substances Data Bank. Infliximab .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Dermatology. 2000;201(1):68-70 [10971067.001]
  • [Cites] Pediatr Dermatol. 1995 Jun;12(2):184-6 [7659649.001]
  • [Cites] Pediatr Dermatol. 2002 Sep-Oct;19(5):388-93 [12383093.001]
  • [Cites] Pediatr Dermatol. 2002 Sep-Oct;19(5):394-401 [12383094.001]
  • [Cites] Arthritis Rheum. 2004 May;50(5):1636-41 [15146434.001]
  • [Cites] N Y State J Med. 1968 Nov 1;68(21):2803-6 [5247013.001]
  • [Cites] Clin Exp Dermatol. 1976 Dec;1(4):287-312 [793743.001]
  • [Cites] Am J Surg Pathol. 1986 Aug;10(8):521-30 [3740350.001]
  • [Cites] J Am Acad Dermatol. 1989 Feb;20(2 Pt 1):214-25 [2644316.001]
  • [Cites] Clin Exp Dermatol. 1991 Mar;16(2):110-3 [2032370.001]
  • [Cites] J Am Acad Dermatol. 1992 Feb;26(2 Pt 2):322-5 [1569251.001]
  • [Cites] Pathol Annu. 1992;27 Pt 2:51-87 [1584628.001]
  • [Cites] J Cutan Pathol. 1994 Oct;21(5):461-6 [7868759.001]
  • [Cites] Clin Exp Dermatol. 1994 Nov;19(6):511-4 [7889677.001]
  • [Cites] Clin Exp Dermatol. 2000 Nov;25(8):627-30 [11167978.001]
  • (PMID = 15677546.001).
  • [ISSN] 0021-9746
  • [Journal-full-title] Journal of clinical pathology
  • [ISO-abbreviation] J. Clin. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antibodies, Monoclonal; 0 / Gastrointestinal Agents; B72HH48FLU / Infliximab
  • [Other-IDs] NLM/ PMC1770572
  •  go-up   go-down


78. Rhee DY, Lee HW, Chung WK, Chang SE, Lee MW, Choi JH, Moon KC, Koh JK: Giant dermatofibroma with granular cell changes: side-effect of bee-venom acupuncture? Clin Exp Dermatol; 2009 Jul;34(5):e18-20
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Dermatofibroma (DF) is a common benign fibrohistiocytic tumour with a predilection for the legs in middle-aged women.
  • Granular cell change is typical of granular cell tumour, but can be observed in diverse cell lineages.
  • [MeSH-major] Acupuncture Therapy / adverse effects. Bee Venoms / adverse effects. Histiocytoma, Benign Fibrous / etiology. Skin Neoplasms / etiology

  • Genetic Alliance. consumer health - Dermatofibroma.
  • MedlinePlus Health Information. consumer health - Acupuncture.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19486038.001).
  • [ISSN] 1365-2230
  • [Journal-full-title] Clinical and experimental dermatology
  • [ISO-abbreviation] Clin. Exp. Dermatol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Bee Venoms
  •  go-up   go-down


79. Roijer E, de Bruijn HW, Dahlén U, ten Hoor K, Lundin M, Nilsson K, Soderstrom K, Nilsson O: Squamous cell carcinoma antigen isoforms in serum from cervical cancer patients. Tumour Biol; 2006;27(3):142-52
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Serum samples from patients with benign skin diseases (psoriasis and eczema) were also selected based on elevated SCCA levels.
  • SCCA2 did not show improved tumor specificity as compared to SCCA1.
  • [MeSH-major] Antigens, Neoplasm / blood. Carcinoma, Squamous Cell / diagnosis. Enzyme-Linked Immunosorbent Assay. Serpins / blood. Uterine Cervical Neoplasms / diagnosis


80. Haykal S, Al Habeeb AS, Goldstein DP, Murray CA, Ghazarian D: Infundibular carcinoma of the skin: a distinct morphological and immunohistochemical entity. J Clin Pathol; 2010 May;63(5):455-62
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Infundibular carcinoma of the skin: a distinct morphological and immunohistochemical entity.
  • This report describes a new entity which has been defined as infundibular carcinoma (IC) of the skin.
  • These include the macroscopic and the microscopic site of the tumour as well as its histomorphological and immunohistochemical patterns.
  • A brief review of benign and malignant tumours of the pilar unit and the differential diagnosis of IC is also provided.
  • [MeSH-major] Carcinoma / pathology. Hair Diseases / pathology. Hair Follicle. Skin Neoplasms / pathology
  • [MeSH-minor] Diagnosis, Differential. Humans. Immunohistochemistry. Male. Middle Aged

  • MedlinePlus Health Information. consumer health - Hair Problems.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20418236.001).
  • [ISSN] 1472-4146
  • [Journal-full-title] Journal of clinical pathology
  • [ISO-abbreviation] J. Clin. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] England
  • [Number-of-references] 24
  •  go-up   go-down


81. Oon HH, Kumarasinghe SP: Subungual squamous cell carcinoma masquerading as a melanotic macule. Singapore Med J; 2008 Mar;49(3):e76-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Diagnosis is often delayed because it presents with minimal nail changes and mimics a number of benign nail conditions.
  • Wide local excision with full thickness skin grafting was performed.
  • Physicians should have a high index of clinical suspicion as early nail biopsy and prompt tumour clearance can preserve joint function.
  • [MeSH-major] Carcinoma, Squamous Cell / diagnosis. Nail Diseases / diagnosis. Skin Neoplasms / diagnosis
  • [MeSH-minor] Adult. Diagnosis, Differential. Humans. Male. Melanosis / diagnosis. Time Factors


82. Sapp M, Bienkowska-Haba M: Viral entry mechanisms: human papillomavirus and a long journey from extracellular matrix to the nucleus. FEBS J; 2009 Dec;276(24):7206-16
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Papillomaviruses are epitheliotropic non-enveloped double-stranded DNA viruses, whose replication is strictly dependent on the terminally differentiating tissue of the epidermis.
  • They induce self-limiting benign tumors of skin and mucosa, which may progress to malignancy (e.g. cervical carcinoma).

  • COS Scholar Universe. author profiles.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Virol. 2007 Jul;81(14):7435-48 [17475643.001]
  • [Cites] Nat Med. 2007 Jul;13(7):857-61 [17603495.001]
  • [Cites] J Biol Chem. 2007 Aug 17;282(33):24416-29 [17588944.001]
  • [Cites] J Virol. 2007 Sep;81(18):9922-31 [17626097.001]
  • [Cites] J Biol Chem. 2007 Sep 21;282(38):27913-22 [17640876.001]
  • [Cites] J Virol. 2007 Oct;81(20):10970-80 [17686860.001]
  • [Cites] J Biol Chem. 2007 Oct 26;282(43):31803-11 [17804402.001]
  • [Cites] J Virol. 2008 May;82(9):4638-46 [18305047.001]
  • [Cites] J Virol. 2008 Jun;82(11):5190-7 [18367526.001]
  • [Cites] J Virol. 2008 Jul;82(13):6288-98 [18417596.001]
  • [Cites] Am J Ther. 2008 Jul-Aug;15(4):304-11 [18645330.001]
  • [Cites] PLoS Pathog. 2008;4(9):e1000148 [18773072.001]
  • [Cites] J Virol. 2008 Oct;82(19):9505-12 [18667513.001]
  • [Cites] PLoS One. 2008;3(10):e3313 [18836553.001]
  • [Cites] Virology. 2008 Nov 10;381(1):16-21 [18834609.001]
  • [Cites] J Virol. 2008 Dec;82(24):12565-8 [18829767.001]
  • [Cites] J Virol. 2004 Dec;78(24):13447-54 [15564455.001]
  • [Cites] J Virol. 2005 Mar;79(5):2839-46 [15709003.001]
  • [Cites] J Virol. 2005 Jun;79(11):6723-31 [15890910.001]
  • [Cites] J Virol. 2005 Jun;79(11):6838-47 [15890923.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Jun 28;102(26):9311-6 [15958530.001]
  • [Cites] J Virol. 2006 Jan;80(2):759-68 [16378978.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Jan 31;103(5):1522-7 [16432208.001]
  • [Cites] Virology. 2006 Mar 30;347(1):147-59 [16376962.001]
  • [Cites] J Virol. 2006 Jul;80(13):6691-6 [16775357.001]
  • [Cites] PLoS Pathog. 2006 Jul;2(7):e69 [16839203.001]
  • [Cites] EMBO J. 2002 Sep 16;21(18):4754-62 [12234916.001]
  • [Cites] Int J Biochem Cell Biol. 2003 Feb;35(2):125-9 [12479862.001]
  • [Cites] J Virol. 2003 Mar;77(6):3531-41 [12610128.001]
  • [Cites] J Virol. 2003 Mar;77(6):3846-50 [12610160.001]
  • [Cites] J Virol. 2003 Apr;77(8):4818-26 [12663788.001]
  • [Cites] Virology. 2003 Mar 1;307(1):1-11 [12667809.001]
  • [Cites] Virology. 2003 Sep 15;314(1):161-7 [14517069.001]
  • [Cites] J Virol. 2003 Nov;77(21):11625-32 [14557648.001]
  • [Cites] J Virol. 2003 Dec;77(24):12961-7 [14645552.001]
  • [Cites] J Virol. 2003 Dec;77(24):13125-35 [14645569.001]
  • [Cites] J Virol. 2004 Jan;78(2):751-7 [14694107.001]
  • [Cites] Virology. 2004 Feb 5;319(1):152-61 [14967496.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Sep 28;101(39):14252-7 [15383670.001]
  • [Cites] J Virol. 2004 Nov;78(22):12179-88 [15507604.001]
  • [Cites] J Cell Biol. 1991 Aug;114(3):585-95 [1860887.001]
  • [Cites] Biophys J. 1991 Dec;60(6):1445-56 [1663794.001]
  • [Cites] Science. 1992 Aug 14;257(5072):971-3 [1323879.001]
  • [Cites] Annu Rev Cell Biol. 1992;8:365-93 [1335744.001]
  • [Cites] Proc Natl Acad Sci U S A. 1994 Nov 8;91(23):11035-9 [7972004.001]
  • [Cites] Virology. 1995 Feb 20;207(1):136-42 [7871722.001]
  • [Cites] J Gen Virol. 1995 Sep;76 ( Pt 9):2407-12 [7561785.001]
  • [Cites] Virology. 1995 Nov 10;213(2):321-7 [7491757.001]
  • [Cites] J Virol. 1996 Jul;70(7):4791-4 [8676509.001]
  • [Cites] J Virol. 1996 Sep;70(9):5875-83 [8709207.001]
  • [Cites] Virology. 1997 Jan 20;227(2):474-83 [9018146.001]
  • [Cites] J Virol. 1997 Apr;71(4):2934-9 [9060652.001]
  • [Cites] J Virol. 1997 May;71(5):3834-9 [9094659.001]
  • [Cites] J Virol. 1998 Mar;72(3):2160-7 [9499072.001]
  • [Cites] J Virol. 1998 Jul;72(7):6186-9 [9621087.001]
  • [Cites] J Biol Chem. 1999 Feb 26;274(9):5810-22 [10026203.001]
  • [Cites] Genes Dev. 2009 Jan 15;23(2):181-94 [19131434.001]
  • [Cites] J Virol. 2009 Mar;83(5):2067-74 [19073722.001]
  • [Cites] PLoS One. 2009;4(2):e4463 [19214230.001]
  • [Cites] PLoS Pathog. 2009 Feb;5(2):e1000318 [19247434.001]
  • [Cites] PLoS Pathog. 2009 Jul;5(7):e1000524 [19629175.001]
  • [Cites] J Virol. 2007 Aug;81(16):8784-92 [17553881.001]
  • [Cites] Virology. 2000 May 10;270(2):254-7 [10792983.001]
  • [Cites] Hum Gene Ther. 2000 May 20;11(8):1165-76 [10834618.001]
  • [Cites] Mol Cell. 2000 Mar;5(3):557-67 [10882140.001]
  • [Cites] J Cell Biochem. 2000 Aug 2;79(2):225-38 [10967550.001]
  • [Cites] J Virol. 2001 Feb;75(3):1565-70 [11152531.001]
  • [Cites] J Virol. 2001 Mar;75(5):2331-6 [11160736.001]
  • [Cites] J Virol. 2001 May;75(9):4332-42 [11287582.001]
  • [Cites] J Virol. 2001 Aug;75(16):7727-31 [11462046.001]
  • [Cites] J Virol. 2001 Oct;75(19):9201-9 [11533183.001]
  • [Cites] Virology. 2002 Aug 1;299(2):279-287 [12202231.001]
  • [Cites] J Virol. 1999 Jun;73(6):4882-9 [10233949.001]
  • [Cites] J Virol. 1999 Jun;73(6):4972-82 [10233959.001]
  • [Cites] J Cell Biochem. 1999 Sep 15;74(4):628-37 [10440932.001]
  • [Cites] J Med Virol. 2005 Jan;75(1):114-21 [15543569.001]
  • [Cites] J Virol. 2006 Sep;80(18):8940-50 [16940506.001]
  • [Cites] Virol J. 2006;3:83 [17014700.001]
  • [Cites] Virology. 2007 Feb 20;358(2):266-72 [17010405.001]
  • [Cites] Virol J. 2007;4:19 [17324266.001]
  • (PMID = 19878308.001).
  • [ISSN] 1742-4658
  • [Journal-full-title] The FEBS journal
  • [ISO-abbreviation] FEBS J.
  • [Language] ENG
  • [Grant] United States / NIAID NIH HHS / AI / R01 AI081809-01A1; United States / NIAID NIH HHS / AI / R01 AI081809; United States / NCRR NIH HHS / RR / P20 RR018724; United States / NCRR NIH HHS / RR / P20-RR018724; United States / NIAID NIH HHS / AI / AI081809-01A1
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Capsid Proteins; 0 / HPV L1 protein, Human papillomavirus; 0 / Heparan Sulfate Proteoglycans; 0 / Oncogene Proteins, Viral
  • [Number-of-references] 80
  • [Other-IDs] NLM/ NIHMS160680; NLM/ PMC2795018
  •  go-up   go-down


83. Białas M, Szczepański W, Szpor J, Okoń K, Kostecka-Matyja M, Hubalewska-Dydejczyk A, Tomaszewska R: Adenomatoid tumour of the adrenal gland: a case report and literature review. Pol J Pathol; 2010;61(2):97-102
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adenomatoid tumour of the adrenal gland: a case report and literature review.
  • Adenomatoid tumour (AT) is a rare, benign neoplasm of mesothelial origin, which usually occurs in the genital tract of both sexes.
  • Occasionally these tumours are found in extra genital locations such as heart, pancreas, skin, pleura, omentum, lymph nodes, retroperitoneum, intestinal mesentery and adrenal gland.
  • The most important thing about these tumours is not to mis-diagnose them as primary malignant or metastatic neoplasms.
  • The tumour was an incidental finding during abdominal CT-scan for an unrelated condition.
  • We also present a review of the literature concerning adrenal gland AT and give possible differential diagnosis.
  • [MeSH-major] Adenomatoid Tumor / pathology. Adrenal Gland Neoplasms / pathology
  • [MeSH-minor] Adult. Asymptomatic Diseases. Biomarkers, Tumor / metabolism. Diagnosis, Differential. Humans. Incidental Findings. Male. Radiography, Abdominal. Tomography, X-Ray Computed

  • MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20924994.001).
  • [ISSN] 1233-9687
  • [Journal-full-title] Polish journal of pathology : official journal of the Polish Society of Pathologists
  • [ISO-abbreviation] Pol J Pathol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Poland
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


84. Naik V, Arsenovic N, Reed M: Eccrine angiomatous hamartoma: a rare multifocal variant with features suggesting trauma. Dermatol Online J; 2009;15(9):6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Eccrine angiomatous hamartoma (EAH) is a rare, benign cutaneous tumor characterized by proliferation of the eccrine gland elements closely associated with capillary angiomatosis and proliferation of other dermal elements, such as adipose tissue, hair and epidermis.
  • Clinically, this condition must be differentiated from other angiomatoses and a definitive diagnosis is based upon histology.
  • Eccrine angiomatous hamartoma is a benign slowly growing lesion for which aggressive treatment is not indicated.
  • [MeSH-major] Eccrine Glands / pathology. Hamartoma / diagnosis. Sweat Gland Diseases / diagnosis
  • [MeSH-minor] Adolescent. Diagnosis, Differential. Female. Friction. Hemangioendothelioma / diagnosis. Hemangioma / diagnosis. Hemangiosarcoma / diagnosis. Humans. Lymphangioma / diagnosis. Nevus, Blue / diagnosis. Skin / injuries. Skin Neoplasms / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19930993.001).
  • [ISSN] 1087-2108
  • [Journal-full-title] Dermatology online journal
  • [ISO-abbreviation] Dermatol. Online J.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


85. Blomberg M, Jeppesen EM, Skovby F, Benfeldt E: FGFR3 mutations and the skin: report of a patient with a FGFR3 gene mutation, acanthosis nigricans, hypochondroplasia and hyperinsulinemia and review of the literature. Dermatology; 2010;220(4):297-305
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] FGFR3 mutations and the skin: report of a patient with a FGFR3 gene mutation, acanthosis nigricans, hypochondroplasia and hyperinsulinemia and review of the literature.
  • Somatic FGFR3 mutations have been found in malignant neoplasms and more recently in several cutaneous elements.
  • In the recent literature, an increasing number of different cutaneous elements have been found to harbor mutations of FGFR3, suggesting that FGFR3 plays a role in the pathogenesis of these elements.
  • We review the present literature, describing studies in which FGFR3 mutations have been investigated in skin lesions: primarily seborrheic keratoses and epidermal nevi, but also other benign skin tumors and a single case of a squamous cell carcinoma.
  • In addition, an overview of the FGFR3 point mutations in relation to each cutaneous element is given.
  • Based on the current knowledge, it seems likely that these cutaneous lesions have a common genetic background.

  • Genetic Alliance. consumer health - Hypochondroplasia.
  • Genetic Alliance. consumer health - Acanthosis Nigricans.
  • MedlinePlus Health Information. consumer health - Dwarfism.
  • The Weizmann Institute of Science GeneCards and MalaCards databases. gene/protein/disease-specific - MalaCards for hypochondroplasia .
  • Hazardous Substances Data Bank. METFORMIN HYDROCHLORIDE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright (c) 2010 S. Karger AG, Basel.
  • (PMID = 20453470.001).
  • [ISSN] 1421-9832
  • [Journal-full-title] Dermatology (Basel, Switzerland)
  • [ISO-abbreviation] Dermatology (Basel)
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Switzerland
  • [Chemical-registry-number] 0 / Blood Glucose; 0 / C-Peptide; 12629-01-5 / Human Growth Hormone; 33515-09-2 / Gonadotropin-Releasing Hormone; 9100L32L2N / Metformin; EC 2.7.10.1 / FGFR3 protein, human; EC 2.7.10.1 / Receptor, Fibroblast Growth Factor, Type 3
  • [Number-of-references] 54
  •  go-up   go-down


86. Mahalingam M, Alter JN, Bhawan J: Multiple cellular neurothekeomas--a case report and review on the role of immunohistochemistry as a histologic adjunct. J Cutan Pathol; 2006 Jan;33(1):51-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Cellular neurothekeoma is a relatively rare, benign cutaneous neoplasm, which usually presents as a solitary papule or nodule involving the head and neck area of young adults.
  • [MeSH-major] Immunohistochemistry / methods. Neoplasms, Multiple Primary / pathology. Neurothekeoma / pathology. Skin Neoplasms / pathology
  • [MeSH-minor] Adult. Biomarkers, Tumor / analysis. Biopsy. Humans. Male. Neoplasm Recurrence, Local

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16441413.001).
  • [ISSN] 0303-6987
  • [Journal-full-title] Journal of cutaneous pathology
  • [ISO-abbreviation] J. Cutan. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Denmark
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


87. Amico P, Vecchio GM, Bisceglia M, Vasquez E, Magro G: Atypical dermatofibroma with predominant epithelioid/deciduoid-like cell component. Histogenetic considerations in the wide spectrum of fibrohistiocytic dermal tumours. Pathologica; 2010 Jun;102(3):115-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Tumour was classified as "atypical dermatofibroma with predominant epithelioid/deciduoid-like cell component".
  • Differential diagnosis with other epitheliod cell dermal tumour- and tumour-like lesions is discussed.
  • [MeSH-major] Histiocytoma, Benign Fibrous / pathology. Histiocytoma, Malignant Fibrous / pathology. Skin Neoplasms / pathology
  • [MeSH-minor] Adult. Biomarkers, Tumor / analysis. Humans. Immunohistochemistry. Male

  • Genetic Alliance. consumer health - Dermatofibroma.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21171517.001).
  • [ISSN] 0031-2983
  • [Journal-full-title] Pathologica
  • [ISO-abbreviation] Pathologica
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Italy
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


88. Takeuchi S, Takahashi A, Motoi N, Yoshimoto S, Tajima T, Yamakoshi K, Hirao A, Yanagi S, Fukami K, Ishikawa Y, Sone S, Hara E, Ohtani N: Intrinsic cooperation between p16INK4a and p21Waf1/Cip1 in the onset of cellular senescence and tumor suppression in vivo. Cancer Res; 2010 Nov 15;70(22):9381-90
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Intrinsic cooperation between p16INK4a and p21Waf1/Cip1 in the onset of cellular senescence and tumor suppression in vivo.
  • Notably, we found the DKO mice to be extremely susceptible to 7,12-dimethylbenz(a)anthracene/12-O-tetradecanoylphorbol-13-acetate-induced skin carcinogenesis that involves oncogenic mutation of the H-ras gene.
  • Mechanistic investigations suggested that the high incidence of cancer in DKO mice likely reflected a cooperative effect of increased benign skin tumor formation caused by p21Waf1/Cip1 loss, with increased malignant conversion of benign skin tumors caused by p16(INK4a) loss.
  • Our findings establish an intrinsic cooperation between p16INK4a and p21Waf1/Cip1 in the onset of cellular senescence and tumor suppression in vivo.
  • [MeSH-major] Cell Aging. Cyclin-Dependent Kinase Inhibitor p16 / metabolism. Cyclin-Dependent Kinase Inhibitor p21 / metabolism. Skin Neoplasms / metabolism

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • Hazardous Substances Data Bank. 12-O-TETRADECANOYLPHORBOL-13-ACETATE .
  • Hazardous Substances Data Bank. 7,12-DIMETHYLBENZ(A)ANTHRACENE .
  • KOMP Repository. gene/protein/disease-specific - KOMP Repository (subscription/membership/fee required).
  • Mouse Genome Informatics (MGI). Mouse Genome Informatics (MGI) .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 AACR.
  • (PMID = 21062974.001).
  • [ISSN] 1538-7445
  • [Journal-full-title] Cancer research
  • [ISO-abbreviation] Cancer Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Cyclin-Dependent Kinase Inhibitor p15; 0 / Cyclin-Dependent Kinase Inhibitor p16; 0 / Cyclin-Dependent Kinase Inhibitor p21; 0 / H2AX protein, mouse; 0 / Histones; 0 / Octamer Transcription Factor-3; 0 / Pou5f1 protein, mouse; 57-97-6 / 9,10-Dimethyl-1,2-benzanthracene; EC 3.6.5.2 / ras Proteins; NI40JAQ945 / Tetradecanoylphorbol Acetate
  •  go-up   go-down


89. Hussain A, Mahmood H, Almusawy H: Moderate size infantile haemangioma of the neck -- conservative or surgical treatment? : a case report. J Med Case Rep; 2008;2:52
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • INTRODUCTION: Infantile haemangioma is the commonest benign tumour in infancy.
  • Clinical assessment and radiological examinations were helpful in confirming the diagnosis.
  • Partial necrosis of the skin flap developed shortly after the operation but healing was complete in eight weeks.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Acta Dermatovenerol Alp Pannonica Adriat. 2005 Jun;14(2):49-52 [16001100.001]
  • [Cites] Ann Chir Plast Esthet. 2006 Aug-Oct;51(4-5):321-9 [16997445.001]
  • [Cites] Ann Chir Plast Esthet. 2006 Aug-Oct;51(4-5):300-9 [17007985.001]
  • [Cites] J Am Acad Dermatol. 2007 Mar;56(3):353-70; quiz 371-4 [17317485.001]
  • [Cites] Int J Pediatr Otorhinolaryngol. 2007 Aug;71(8):1311-5 [17548115.001]
  • [Cites] Am J Med Genet. 1994 Aug 15;52(2):130-5 [7801997.001]
  • [Cites] Pediatr Dermatol. 2004 Jan-Feb;21(1):1-9 [14871317.001]
  • [Cites] AJR Am J Roentgenol. 1998 Jul;171(1):247-52 [9648798.001]
  • [Cites] Dermatol Clin. 1998 Jul;16(3):455-88 [9704205.001]
  • [Cites] Mund Kiefer Gesichtschir. 2000 May;4 Suppl 1:S76-83 [10938646.001]
  • [Cites] Pediatr Hematol Oncol. 2001 Jul-Aug;18(5):335-41 [11452405.001]
  • [Cites] Arch Pediatr. 2004 Feb;11(2):99-107 [14761730.001]
  • [Cites] Pathol Annu. 1993;28 Pt 1:97-120 [8416140.001]
  • (PMID = 18284695.001).
  • [ISSN] 1752-1947
  • [Journal-full-title] Journal of medical case reports
  • [ISO-abbreviation] J Med Case Rep
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2265728
  •  go-up   go-down


90. Lorber A, Wiltgen M, Hofmann-Wellenhof R, Koller S, Weger W, Ahlgrimm-Siess V, Smolle J, Gerger A: Correlation of image analysis features and visual morphology in melanocytic skin tumours using in vivo confocal laser scanning microscopy. Skin Res Technol; 2009 May;15(2):237-41
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Correlation of image analysis features and visual morphology in melanocytic skin tumours using in vivo confocal laser scanning microscopy.
  • BACKGROUND/PURPOSE: In vivo confocal laser scanning microscopy (CLSM) represents a novel imaging tool that allows the non-invasive examination of skin cancer morphology at a quasi histological resolution without biopsy.
  • In this study we examined the correlation between objectively reproducible image-analysis features und visual morphology in melanocytic skin tumours using CLSM.
  • METHODS: Eight hundred and fifty-seven CLSM tumour images including 408 benign nevi and 449 melanoma images were evaluated.
  • Seven classification tree nodes seemed to indicate benign nevi, whereas six nodes were suggestive for melanoma morphology.
  • The visual examination of selected nodes demonstrated that monomorphic melanocytic cells and melanocytic cell nests are characteristic for benign nevi whereas polymorphic melanocytic cells, disarray of melanocytic architecture and poorly defined or absent keratinocyte cell borders are characteristic for melanoma.
  • [MeSH-major] Dermoscopy / methods. Melanoma / pathology. Microscopy, Confocal / methods. Nevus / pathology. Skin Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Birthmarks.
  • MedlinePlus Health Information. consumer health - Melanoma.
  • MedlinePlus Health Information. consumer health - Moles.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19622133.001).
  • [ISSN] 1600-0846
  • [Journal-full-title] Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)
  • [ISO-abbreviation] Skin Res Technol
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] Denmark
  •  go-up   go-down


91. Fenichel I, Garniack A, Morag B, Palti R, Salai M: Percutaneous CT-guided curettage of osteoid osteoma with histological confirmation: a retrospective study and review of the literature. Int Orthop; 2006 Apr;30(2):139-42
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Osteoid osteoma is a benign bone tumour usually occurring in young individuals (10-30 years).
  • The diagnosis was histologically confirmed in 14 cases out of 18 (77%).
  • There were only two minor complications, one case of femoral neuropraxia and one case of skin abrasion.
  • The use of a cannulated drill and a cannulated curette facilitates efficient removal of the tumour and procurement of tissue for diagnosis.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Rofo. 2001 Aug;173(8):708-13 [11570240.001]
  • [Cites] AJNR Am J Neuroradiol. 1998 Nov-Dec;19(10):1955-8 [9874556.001]
  • [Cites] Clin Orthop Relat Res. 1986 Mar;(204):76-85 [3956019.001]
  • [Cites] J Pediatr Orthop. 1990 Jul-Aug;10(4):510-3 [2358492.001]
  • [Cites] J Formos Med Assoc. 1990 May;89(5):366-72 [1977846.001]
  • [Cites] J Pediatr Orthop. 1990 Nov-Dec;10(6):800-4 [2250070.001]
  • [Cites] Radiology. 1991 Oct;181(1):269-71 [1887046.001]
  • [Cites] Rofo. 1991 Dec;155(6):532-7 [1764595.001]
  • [Cites] Radiology. 1992 Apr;183(1):29-33 [1549690.001]
  • [Cites] Radiology. 1993 Aug;188(2):541-7 [8327712.001]
  • [Cites] Rev Rhum Ed Fr. 1993 Jan;60(1):28-36 [8242023.001]
  • [Cites] Radiology. 1994 Apr;191(1):217-23 [8134575.001]
  • [Cites] Pediatr Radiol. 1994;24(3):185-8 [7936795.001]
  • [Cites] Clin Orthop Relat Res. 1995 Jan;(310):170-5 [7641435.001]
  • [Cites] Radiol Med. 1995 Jul-Aug;90(1-2):84-7 [7569103.001]
  • [Cites] Radiology. 1995 Nov;197(2):451-4 [7480692.001]
  • [Cites] Rev Chir Orthop Reparatrice Appar Mot. 1995;81(4):317-25 [8560001.001]
  • [Cites] J Radiol. 1996 Jan;77(1):37-40 [8815223.001]
  • [Cites] Rev Chir Orthop Reparatrice Appar Mot. 1996;82(8):737-42 [9097860.001]
  • [Cites] Dtsch Med Wochenschr. 1997 Apr 18;122(16):507-10 [9162624.001]
  • [Cites] Unfallchirurg. 1997 Jul;100(7):536-40 [9340778.001]
  • [Cites] Radiol Clin North Am. 1998 May;36(3):559-66 [9597073.001]
  • [Cites] Radiology. 1984 Nov;153(2):543-4 [6484185.001]
  • (PMID = 16474938.001).
  • [ISSN] 0341-2695
  • [Journal-full-title] International orthopaedics
  • [ISO-abbreviation] Int Orthop
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Germany
  • [Number-of-references] 23
  • [Other-IDs] NLM/ PMC2532079
  •  go-up   go-down


92. Tripathy BB, Saha K, Shukla RM, Mukhopadhyay M, Mukhopadhyay B: Gastric teratoma in a female infant. J Indian Med Assoc; 2010 Oct;108(10):694-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • This patient, aged one year, female was having a massive benign gastric teratoma.
  • The size of the tumour was 22 cm x 10 cm x 8 cm and weighted 2.250 kg making it one of the largest gastric teratoma.
  • The tumour was removed by surgery.
  • Histopathology revealed presence of all 3 elements in the form of skin, cartilage, fibrofatty tissue, blood vessels and gland with tall columnar epithelium.
  • [MeSH-major] Stomach Neoplasms / diagnosis. Stomach Neoplasms / surgery. Teratoma / diagnosis. Teratoma / surgery
  • [MeSH-minor] Diagnosis, Differential. Diagnostic Imaging. Female. Humans. Infant

  • Genetic Alliance. consumer health - Teratoma.
  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21510560.001).
  • [ISSN] 0019-5847
  • [Journal-full-title] Journal of the Indian Medical Association
  • [ISO-abbreviation] J Indian Med Assoc
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] India
  •  go-up   go-down


93. Casanova D, Norat F, Bardot J, Magalon G: [Hemangioma: complications]. Ann Chir Plast Esthet; 2006 Aug-Oct;51(4-5):293-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Hemangioma (HMG) is a benign tumour of the child generally evolving to spontaneous regression.
  • [MeSH-major] Hemangioma / complications. Skin Neoplasms / complications
  • [MeSH-minor] Cardiac Output, Low / etiology. Child. Disseminated Intravascular Coagulation / physiopathology. Humans. Prognosis. Skin Diseases / etiology. Syndrome. Thrombocytopenia / physiopathology

  • Genetic Alliance. consumer health - Hemangioma.
  • MedlinePlus Health Information. consumer health - Birthmarks.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16997443.001).
  • [ISSN] 0294-1260
  • [Journal-full-title] Annales de chirurgie plastique et esthétique
  • [ISO-abbreviation] Ann Chir Plast Esthet
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


94. Novak NP, Kaić G, Tomasović-Loncarić C, Zic R, Skoro M, Ostović KT: Fine-needle aspiration cytology of apocrine hidradenoma. Coll Antropol; 2010 Jun;34(2):671-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • An apocrine hidradenoma is a benign adnexal neoplasm, usually covered by intact skin, but may show superficial ulceration and serous discharge.
  • This feature is raising the possibility of malignancy as it was in our case of macroscopically suspicious tumour.
  • We described cytomorphologic features of cutaneous nodule that might be a lead to the cytologic diagnosis of hidradenoma, but primary or secondary malignant tumour has been ruled out first.
  • [MeSH-major] Acrospiroma / pathology. Sweat Gland Neoplasms / pathology
  • [MeSH-minor] Aged. Biopsy, Fine-Needle. Diagnosis, Differential. Humans. Male. Skin Neoplasms / pathology. Skin Neoplasms / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20698151.001).
  • [ISSN] 0350-6134
  • [Journal-full-title] Collegium antropologicum
  • [ISO-abbreviation] Coll Antropol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Croatia
  •  go-up   go-down


95. Faller WJ, Rafferty M, Hegarty S, Gremel G, Ryan D, Fraga MF, Esteller M, Dervan PA, Gallagher WM: Metallothionein 1E is methylated in malignant melanoma and increases sensitivity to cisplatin-induced apoptosis. Melanoma Res; 2010 Oct;20(5):392-400
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • DNA methylation plays a major role in cancer by silencing tumour suppressor genes.
  • Examination of a larger cohort of samples showed that 1 of 17 (6%) of the benign naevi, 16 of 43 (37%) primary tumours and 6 of 13 (46%) of the metastases displayed MT1E methylation.
  • Overall, these studies suggest that MT1E is a potential tumour suppressor gene, whose loss may promote resistance to apoptosis-inducing therapies.
  • [MeSH-major] Apoptosis / drug effects. Cisplatin / pharmacology. DNA Methylation. Drug Resistance, Neoplasm / genetics. Melanoma / genetics. Metallothionein / genetics. Skin Neoplasms / genetics
  • [MeSH-minor] Antineoplastic Agents / pharmacology. Cell Line, Tumor. Cells, Cultured. Gene Expression Profiling. Gene Expression Regulation, Neoplastic. Genes, Tumor Suppressor / physiology. Humans. Microarray Analysis. Transfection

  • MedlinePlus Health Information. consumer health - Melanoma.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • Hazardous Substances Data Bank. CIS-DIAMINEDICHLOROPLATINUM .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20848733.001).
  • [ISSN] 1473-5636
  • [Journal-full-title] Melanoma research
  • [ISO-abbreviation] Melanoma Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / metallothionein 1E protein, human; 9038-94-2 / Metallothionein; Q20Q21Q62J / Cisplatin
  •  go-up   go-down


96. Antony FC, Sanclemente G, Shaikh H, Trelles AS, Calonje E: Pigment synthesizing melanoma (so-called animal type melanoma): a clinicopathological study of 14 cases of a poorly known distinctive variant of melanoma. Histopathology; 2006 May;48(6):754-62
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The head and neck represented the most common site.
  • The clinical diagnosis was of melanoma in seven cases, blue naevus in three cases, benign naevus in three cases and a pigmented basal cell carcinoma in one case.
  • The histological diagnosis of PSM was predicated on the basis of an asymmetrical, predominantly intradermal tumour formed of deeply pigmented, round or short, spindle-shaped dendritic melanocytes with some degree of hyperchromatism and a single nucleolus.
  • [MeSH-major] Melanoma / pathology. Skin Neoplasms / pathology
  • [MeSH-minor] Adolescent. Adult. Antigens, Neoplasm. Child. Child, Preschool. Female. Follow-Up Studies. Humans. Immunohistochemistry. MART-1 Antigen. Male. Melanocytes / chemistry. Melanocytes / pathology. Melanoma-Specific Antigens. Middle Aged. Neoplasm Proteins / analysis. Neoplasm Recurrence, Local. Nevus, Blue / metabolism. Nevus, Blue / pathology. Nevus, Pigmented / metabolism. Nevus, Pigmented / pathology. S100 Proteins / analysis

  • MedlinePlus Health Information. consumer health - Melanoma.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16681693.001).
  • [ISSN] 0309-0167
  • [Journal-full-title] Histopathology
  • [ISO-abbreviation] Histopathology
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antigens, Neoplasm; 0 / MART-1 Antigen; 0 / MLANA protein, human; 0 / Melanoma-Specific Antigens; 0 / Neoplasm Proteins; 0 / S100 Proteins
  •  go-up   go-down


97. Karwacki MW, Woźniak W: [Neurofibromatosis--an inborn genetic disorder with susceptibility to neoplasia]. Med Wieku Rozwoj; 2006 Jul-Sep;10(3 Pt 2):923-48
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Neurofibromatosis--an inborn genetic disorder with susceptibility to neoplasia].
  • Both are autosomal dominant disorders with 100% penetration, variable expression and 50% rate of new (de novo) mutations.
  • The protein products of both, NF1 andNF2 genes are best known and the genes serve as tumour suppressors.
  • Nf-2 is a multisystem genetic disorder associated with bilateral vestibular schwannomas, spinal cord schwannomas, meningiomas, gliomas, and juvenile cataracts with a paucity of cutaneous features, which are seen more consistently in Nf-1.
  • The cardinal features of Nf-1 are cafe-au-lait spots, axillary and inguinal freckling, cutaneous neurofibromas, and iris hamartomas (Lisch nodules).
  • Optic gliomas and both malignant and benign peripheral nerve sheet tumours are the most common malignancies arising in Nf-1 patients.
  • [MeSH-major] Genes, Neurofibromatosis 1. Genes, Neurofibromatosis 2. Neurofibromatoses / diagnosis. Neurofibromatoses / genetics
  • [MeSH-minor] Comorbidity. Cranial Nerve Neoplasms / diagnosis. Cranial Nerve Neoplasms / epidemiology. Cranial Nerve Neoplasms / genetics. Genetic Predisposition to Disease. Humans. Neurofibromatosis 1 / diagnosis. Neurofibromatosis 1 / genetics. Neurofibromatosis 2 / diagnosis. Neurofibromatosis 2 / genetics. Optic Nerve Diseases / diagnosis. Optic Nerve Diseases / genetics. Pigmentation Disorders / diagnosis. Pigmentation Disorders / genetics. Scoliosis / diagnosis. Scoliosis / epidemiology. Scoliosis / genetics. Skin Neoplasms / diagnosis. Skin Neoplasms / epidemiology. Skin Neoplasms / genetics. Soft Tissue Neoplasms / diagnosis. Soft Tissue Neoplasms / epidemiology. Soft Tissue Neoplasms / genetics. Spinal Cord Neoplasms / diagnosis. Spinal Cord Neoplasms / epidemiology. Spinal Cord Neoplasms / genetics


98. Gardner RJ, Hobolth A, Jensen EB, Sørensen FB: Shape discrimination by total curvature, with a view to cancer diagnostics. J Microsc; 2005 Jan;217(Pt 1):49-59
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Total curvature is capable of revealing shape differences on a local scale, as demonstrated by the analysis of two data sets of malignant and normal or benign tumour cell nuclear profiles.
  • [MeSH-major] Image Processing, Computer-Assisted / methods. Lymphoma, T-Cell / pathology. Melanoma / pathology. Nevus, Pigmented / pathology. Skin Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Melanoma.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15655062.001).
  • [ISSN] 0022-2720
  • [Journal-full-title] Journal of microscopy
  • [ISO-abbreviation] J Microsc
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  •  go-up   go-down


99. Conscience I, Jovenin N, Coissard C, Lorenzato M, Durlach A, Grange F, Birembaut P, Clavel C, Bernard P: P16 is overexpressed in cutaneous carcinomas located on sun-exposed areas. Eur J Dermatol; 2006 Sep-Oct;16(5):518-22
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] P16 is overexpressed in cutaneous carcinomas located on sun-exposed areas.
  • BACKGROUND: Recently, an increased expression of P16, a cell cycle regulatory tumor suppressor protein, has been demonstrated in cervical squamous neoplasms as a marker of malignancy.
  • In contrast, studies performed in skin carcinomas led to contradictory results.
  • OBJECTIVES: Our first aim was to evaluate P16 expression in different types of non-melanoma skin cancers compared with normal skin and benign tumors.
  • The second aim was to evaluate the relationship between P16 expression and the location of skin tumors (i.e. exposed versus non exposed sites).
  • Finally, we also studied Ki67 expression in skin carcinomas and control biopsies.
  • METHODS: Skin biopsy specimens with typical histologic features of squamous cell carcinoma (SCC; n = 30), Bowen's disease (BD; n = 17), basal cell carcinoma (BCC; n = 10), seborrheic keratosis (SK; n = 10) and normal human skin (NHS; n = 9) were obtained from 76 patients seen at our institution between 2001 and 2003.
  • RESULTS: P16 overexpression was observed in 58% of cutaneous carcinomas (SCC: 60%; BD: 58%; BCC: 50%) versus 0% of SK or NHS (0%) (p = 0.006).
  • Ki67 expression in over 5% of tumour cells was observed in 69% of cutaneous carcinomas (SCC: 54%; BD: 76%; BCC: 80%) versus 16% in the group including SK (30%) and NHS (0%) (p = 0.04).
  • Overexpression of P16 was associated with a high rate of Ki67 positive tumour cells in 23/57 malignant skin tumors (40%).
  • Sixty-eight percent of tumors located on sun-exposed areas versus 23% of those located on non sun-exposed areas overexpressed P16 (p = 0.02).
  • CONCLUSION: Our study demonstrated that the expression of P16 and Ki67 is associated with skin carcinomas.
  • Within cutaneous carcinoma specimens, P16 overexpression was significantly associated with the location on sun-exposed areas, suggesting a possible induction of P16 overexpression by UV radiation.
  • [MeSH-major] Cyclin-Dependent Kinase Inhibitor p16 / metabolism. Skin Neoplasms / metabolism. Ultraviolet Rays

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17101472.001).
  • [ISSN] 1167-1122
  • [Journal-full-title] European journal of dermatology : EJD
  • [ISO-abbreviation] Eur J Dermatol
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] France
  • [Chemical-registry-number] 0 / Cyclin-Dependent Kinase Inhibitor p16; 0 / Ki-67 Antigen
  •  go-up   go-down


100. Cross NJ, Fung DE: Tuberous sclerosis: a case report. Spec Care Dentist; 2010 Jul-Aug;30(4):157-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Tuberous sclerosis is an inherited neurocutaneous disorder that occurs in approximately 1 in 7,500 live births.
  • It is characterized by benign neoplasms of the skin, heart, kidneys, lungs, central nervous system, and mucosa.
  • Histologically, the appearance was described as nonspecific, but was consistent with a diagnosis of tuberous sclerosis.
  • [MeSH-major] Gingival Diseases / diagnosis. Tuberous Sclerosis / diagnosis
  • [MeSH-minor] Biopsy. Child. Dental Care for Disabled. Dental Caries / diagnosis. Female. Humans. Incisor / abnormalities

  • Genetic Alliance. consumer health - Tuberous sclerosis.
  • MedlinePlus Health Information. consumer health - Gum Disease.
  • MedlinePlus Health Information. consumer health - Tuberous Sclerosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20618782.001).
  • [ISSN] 1754-4505
  • [Journal-full-title] Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry
  • [ISO-abbreviation] Spec Care Dentist
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down






Advertisement